Tissue invasion and metastasis: Molecular, biological and clinical perspectives

Hanahan, 2000, The hallmarks of cancer, Cell, 100, 57, 10.1016/S0092-8674(00)81683-9 Gupta, 2006, Cancer metastasis: building a framework, Cell, 127, 679, 10.1016/j.cell.2006.11.001 Morgan, 2009, Disseminated tumor cells in prostate cancer patients after radical prostatectomy and without evidence of disease predicts biochemical recurrence, Clin Cancer Res, 15, 677, 10.1158/1078-0432.CCR-08-1754 Talmadge, 2010, AACR centennial series: the biology of cancer metastasis: historical perspective, Cancer Res, 70, 5649, 10.1158/0008-5472.CAN-10-1040 Sporn, 1997, The war on cancer: a review, Ann N Y Acad Sci, 833, 137, 10.1111/j.1749-6632.1997.tb48599.x Chambers, 2002, Dissemination and growth of cancer cells in metastatic sites, Nat Rev Cancer, 2, 563, 10.1038/nrc865 Cavallaro, 2004, Multitasking in tumor progression: signaling functions of cell adhesion molecules, Ann N Y Acad Sci, 1014, 58, 10.1196/annals.1294.006 Cavallaro, 2004, Cell adhesion and signalling by cadherins and Ig-CAMs in cancer, Nat Rev Cancer, 4, 118, 10.1038/nrc1276 Bogenrieder, 2003, Axis of evil: molecular mechanisms of cancer metastasis, Oncogene, 22, 6524, 10.1038/sj.onc.1206757 St Croix, 1998, E-cadherin-dependent growth suppression is mediated by the cyclin-dependent kinase inhibitor p27(KIP1), J Cell Biol, 142, 557, 10.1083/jcb.142.2.557 Migita, 2008, Inverse relationship between E-cadherin and p27Kip1 expression in renal cell carcinoma, Int J Oncol, 33, 41 Jiang, 1998, The effects of n-6 polyunsaturated fatty acids on the expression of nm-23 in human cancer cells, Br J Cancer, 77, 731, 10.1038/bjc.1998.120 Hawkins, 1998, Apoptotic death of pancreatic cancer cells induced by polyunsaturated fatty acids varies with double bond number and involves an oxidative mechanism, J Pathol, 185, 61, 10.1002/(SICI)1096-9896(199805)185:1<61::AID-PATH49>3.0.CO;2-8 Jiang, 1995, Regulation of the expression of E-cadherin on human cancer cells by gamma-linolenic acid (GLA), Cancer Res, 55, 5043 Jiang, 1998, Essential fatty acids: molecular and cellular basis of their anti-cancer action and clinical implications, Crit Rev Oncol Hematol, 27, 179, 10.1016/S1040-8428(98)00003-1 Eynard, 1998, Eicosatrienoic acid (20:3 n-9) inhibits the expression of E-cadherin and desmoglein in human squamous cell carcinoma in vitro, Prostaglandins Leukot Essent Fatty Acids, 59, 371, 10.1016/S0952-3278(98)90098-9 Mineta, 2011, Predicted expansion of the claudin multigene family, FEBS Lett, 585, 606, 10.1016/j.febslet.2011.01.028 Mullin, 1996, Chronic exposure of LLC-PK1 epithelia to the phorbol ester TPA produces polyp-like foci with leaky tight junctions and altered protein kinase C-α expression and localization, Exp Cell Res, 227, 12, 10.1006/excr.1996.0244 Mullin, 1997, Transepithelial paracellular leakiness induced by chronic phorbol ester exposure correlates with polyp-like foci and redistribution of protein kinase C-alpha, Carcinogenesis, 18, 2339, 10.1093/carcin/18.12.2339 Collares-Buzato, 1998, Increased tyrosine phosphorylation causes redistribution of adherens junction and tight junction proteins and perturbs paracellular barrier function in MDCK epithelia, Eur J Cell Biol, 76, 85, 10.1016/S0171-9335(98)80020-4 Krause, 2008, Structure and function of claudins, Biochim Biophys Acta, 1778, 631, 10.1016/j.bbamem.2007.10.018 Soini, 2005, Expression of claudins 1, 2, 3, 4, 5 and 7 in various types of tumours, Histopathology, 46, 551, 10.1111/j.1365-2559.2005.02127.x Soini, 2006, Claudins in differential diagnosis between mesothelioma and metastatic adenocarcinoma of the pleura, J Clin Pathol, 59, 250, 10.1136/jcp.2005.028589 Morita, 1999, Claudin-11/OSP-based tight junctions of myelin sheaths in brain and sertoli cells in testis, J Cell Biol, 145, 579, 10.1083/jcb.145.3.579 Soini, 2011, Claudins in lung diseases, Respir Res, 12, 70, 10.1186/1465-9921-12-70 González-Mariscal, 2007, Role of tight junctions in cell proliferation and cancer, Prog Histochem Cytochem, 42, 1, 10.1016/j.proghi.2007.01.001 Findley, 2009, Regulation and roles for claudin-family tight junction proteins, IUBMB Life, 61, 431, 10.1002/iub.175 Peter, 2009, Epidermal growth factor receptor and claudin-2 participate in A549 permeability and remodeling: implications for non-small cell lung cancer tumor colonization, Mol Carcinog, 48, 488, 10.1002/mc.20485 Singh, 2004, Epidermal growth factor receptor activation differentially regulates claudin expression and enhances transepithelial resistance in madin-darby canine kidney cells, J Biol Chem, 279, 3543, 10.1074/jbc.M308682200 D'Souza, 2005, Phosphorylation of claudin-3 at threonine 192 by cAMP-dependent protein kinase regulates tight junction barrier function in ovarian cancer cells, J Biol Chem, 280, 26233, 10.1074/jbc.M502003200 Ikari, 2006, Phosphorylation of paracellin-1 at Ser217 by protein kinase A is essential for localization in tight junctions, J Cell Sci, 119, 1781, 10.1242/jcs.02901 Tanaka, 2005, EphA2 phosphorylates the cytoplasmic tail of claudin-4 and mediates paracellular permeability, J Biol Chem, 280, 42375, 10.1074/jbc.M503786200 Clarke, 2000, Modification of tight junction function by protein kinase C isoforms, Adv Drug Deliv Rev, 41, 283, 10.1016/S0169-409X(00)00047-8 Wu, 2000, Evidence for regulation of the PTEN tumor suppressor by a membrane-localized multi-PDZ domain containing scaffold protein MAGI-2, Proc Natl Acad Sci U S A, 97, 4233, 10.1073/pnas.97.8.4233 Yamauchi, 2004, Disease-causing mutant WNK4 increases paracellular chloride permeability and phosphorylates claudins, Proc Natl Acad Sci U S A, 101, 4690, 10.1073/pnas.0306924101 Kang, 2005, Familial hypomagnesemia with hypercalciuria and nephrocalcinosis associated with CLDN16 mutations, Pediatr Nephrol, 20, 1490, 10.1007/s00467-005-1969-7 Sauer, 2005, Reduced expression of Claudin-7 in fine needle aspirates from breast carcinomas correlate with grading and metastatic disease, Cytopathology, 16, 193, 10.1111/j.1365-2303.2005.00257.x Michl, 2003, Claudin-4 expression decreases invasiveness and metastatic potential of pancreatic cancer, Cancer Res, 63, 6265 Prasad, 2005, Inflammatory processes have differential effects on claudins 2, 3 and 4 in colonic epithelial cells, Lab Invest, 85, 1139, 10.1038/labinvest.3700316 Tedelind, 2003, Interferon-gamma down-regulates claudin-1 and impairs the epithelial barrier function in primary cultured human thyrocytes, Eur J Endocrinol, 149, 215, 10.1530/eje.0.1490215 Balkovetz, 2004, Gene expression alterations during HGF-induced dedifferentiation of a renal tubular epithelial cell line (MDCK) using a novel canine DNA microarray, Am J Physiol Renal Physiol, 286, F702, 10.1152/ajprenal.00270.2003 Martínez-estrada, 2006, The transcription factors Slug and Snail act as repressors of Claudin-1 expression in epithelial cells, Biochem J, 394, 449, 10.1042/BJ20050591 Escaffit, 2005, Differential expression of claudin-2 along the human intestine: implication of GATA-4 in the maintenance of claudin-2 in differentiating cells, J Cell Physiol, 203, 15, 10.1002/jcp.20189 Sakaguchi, 2002, Cloning of the human claudin-2 5′-flanking region revealed a TATA-less promoter with conserved binding sites in mouse and human for caudal-related homeodomain proteins and hepatocyte nuclear factor-1α, J Biol Chem, 277, 21361, 10.1074/jbc.M110261200 Krishnan, 2010, HDAC inhibitors regulate claudin-1 expression in colon cancer cells through modulation of mRNA stability, Oncogene, 29, 305, 10.1038/onc.2009.324 Shiou, 2007, Smad4 regulates claudin-1 expression in a transforming growth factor-β-independent manner in colon cancer cells, Cancer Res, 67, 1571, 10.1158/0008-5472.CAN-06-1680 Tan, 2004, Regulation of tumor angiogenesis by integrin-linked kinase (ILK), Cancer Cell, 5, 79, 10.1016/S1535-6108(03)00281-2 Kominsky, 2003, Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast, Oncogene, 22, 2021, 10.1038/sj.onc.1206199 Usami, 2006, Reduced expression of claudin-7 correlates with invasion and metastasis in squamous cell carcinoma of the esophagus, Hum Pathol, 37, 569, 10.1016/j.humpath.2005.12.018 Rangel, 2003, Tight junction proteins claudin-3 and claudin-4 are frequently overexpressed in ovarian cancer but not in ovarian cystadenomas, Clin Cancer Res, 9, 2567 Lee, 2005, Increased expressions of claudin-1 and claudin-7 during the progression of cervical neoplasia, Gynecol Oncol, 97, 53, 10.1016/j.ygyno.2004.11.058 Agarwal, 2005, Claudin-3 and claudin-4 expression in ovarian epithelial cells enhances invasion and is associated with increased matrix metalloproteinase-2 activity, Cancer Res, 65, 7378, 10.1158/0008-5472.CAN-05-1036 Chao, 2009, Claudin-1 is a metastasis suppressor and correlates with clinical outcome in lung adenocarcinoma, Am J Respir Crit Care Med, 179, 123, 10.1164/rccm.200803-456OC Dhawan, 2005, Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer, J Clin Invest, 115, 1765, 10.1172/JCI24543 Gopalakrishnan, 2008, DNA methylation in development and human disease, Mutat Res, 647, 30, 10.1016/j.mrfmmm.2008.08.006 Turksen, 2011, Junctions gone bad: claudins and loss of the barrier in cancer, Biochim Biophys Acta, 1816, 73 Osanai, 2007, Epigenetic silencing of claudin-6 promotes anchorage-independent growth of breast carcinoma cells, Cancer Sci, 98, 1557, 10.1111/j.1349-7006.2007.00569.x Itoh, 1999, Direct binding of three tight junction-associated MAGUKs, ZO-1, ZO-2, and ZO-3, with the COOH termini of claudins, J Cell Biol, 147, 1351, 10.1083/jcb.147.6.1351 Jin, 2008, Wnt and beyond Wnt: multiple mechanisms control the transcriptional property of β-catenin, Cell Signal, 20, 1697, 10.1016/j.cellsig.2008.04.014 Gottardi, 1996, The junction-associated protein, zonula occludens-1, localizes to the nucleus before the maturation and during the remodeling of cell–cell contacts, Proc Natl Acad Sci U S A, 93, 10779, 10.1073/pnas.93.20.10779 Reichert, 2000, The PDZ domains of zonula occludens-1 induce an epithelial to mesenchymal transition of Madin-Darby canine kidney I cells: evidence for a role of β-catenin/Tcf/Lef signaling, J Biol Chem, 275, 9492, 10.1074/jbc.275.13.9492 Miwa, 2001, Involvement of claudin-1 in the beta-catenin/Tcf signaling pathway and its frequent upregulation in human colorectal cancers, Oncol Res, 12, 469, 10.3727/096504001108747477 Mankertz, 2004, Functional crosstalk between Wnt signaling and Cdx-related transcriptional activation in the regulation of the claudin-2 promoter activity, Biochem Biophys Res Commun, 314, 1001, 10.1016/j.bbrc.2003.12.185 Bogenrieder, 2003, Axis of evil: molecular mechanisms of cancer metastasis, Oncogene, 22, 6524, 10.1038/sj.onc.1206757 Miyamori, 2001, Claudin promotes activation of pro-matrix metalloproteinase-2 mediated by membrane-type matrix metalloproteinases, J Biol Chem, 276, 28204, 10.1074/jbc.M103083200 Ip, 2007, Inhibition of hepatocellular carcinoma invasion by suppression of claudin-10 in HLE cells, Mol Cancer Ther, 6, 2858, 10.1158/1535-7163.MCT-07-0453 Lu, 2004, Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis, Clin Cancer Res, 10, 3291, 10.1158/1078-0432.CCR-03-0409 Resnick, 2004, Claudin-1 is a strong prognostic indicator in stage II colonic cancer: a tissue microarray study, Mod Pathol, 18, 511, 10.1038/modpathol.3800301 Myal, 2010, Claudin 1 in breast tumorigenesis: revelation of a possible novel “claudin high” subset of breast cancers, J Biomed Biotechnol, 2010, 956897, 10.1155/2010/956897 Cheung, 2005, Claudin-10 expression level is associated with recurrence of primary hepatocellular carcinoma, Clin Cancer Res, 11, 551, 10.1158/1078-0432.551.11.2 Nacht, 1999, Combining serial analysis of gene expression and array technologies to identify genes differentially expressed in breast cancer, Cancer Res, 59, 5464 Hough, 2000, Large-scale serial analysis of gene expression reveals genes differentially expressed in ovarian cancer, Cancer Res, 60, 6281 Veshnyakova, 2012, Mechanism of Clostridium perfringens enterotoxin interaction with claudin-3/-4 protein suggests structural modifications of the toxin to target specific claudins, J Biol Chem, 287, 1698, 10.1074/jbc.M111.312165 Ebihara, 2006, Preparation of a claudin-targeting molecule using a C-terminal fragment of Clostridium perfringens enterotoxin, J Pharmacol Exp Ther, 316, 255, 10.1124/jpet.105.093351 French, 2009, PKC and PKA phosphorylation affect the subcellular localization of claudin-1 in melanoma cells, Int J Med Sci, 6, 93, 10.7150/ijms.6.93 Hynes, 2002, Integrins: bidirectional, allosteric signaling machines, Cell, 110, 673, 10.1016/S0092-8674(02)00971-6 Turner, 2000, Paxillin and focal adhesion signalling, Nat Cell Biol, 2, E231, 10.1038/35046659 Aruffo, 1990, CD44 is the principal cell surface receptor for hyaluronate, Cell, 61, 1303, 10.1016/0092-8674(90)90694-A Turley, 2002, Signaling properties of hyaluronan receptors, J Biol Chem, 277, 4589, 10.1074/jbc.R100038200 Ponta, 2003, CD44: from adhesion molecules to signalling regulators, Nat Rev Mol Cell Biol, 4, 33, 10.1038/nrm1004 Sironen, 2011, Hyaluronan in human malignancies, Exp Cell Res, 317, 383, 10.1016/j.yexcr.2010.11.017 Zoller, 2011, CD44: can a cancer-initiating cell profit from an abundantly expressed molecule?, Nat Rev Cancer, 11, 254, 10.1038/nrc3023 Gunthert, 1991, A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells, Cell, 65, 13, 10.1016/0092-8674(91)90403-L Toole, 2008, Hyaluronan, CD44 and emmprin: partners in cancer cell chemoresistance, Drug Resist Update, 11, 110, 10.1016/j.drup.2008.04.002 Auvinen, 2013, Increased hyaluronan content and stromal cell CD44 associate with HER2 positivity and poor prognosis in human breast cancer, Int J Cancer, 132, 531, 10.1002/ijc.27707 Ghosh, 2012, CD44: a validated target for improved delivery of cancer therapeutics, Expert Opin Ther Targets, 16, 635, 10.1517/14728222.2012.687374 Wells, 2013, Targeting tumor cell motility as a strategy against invasion and metastasis, Trends Pharmacol Sci, 34, 283, 10.1016/j.tips.2013.03.001 Jiang, 2005, Hepatocyte growth factor, its receptor, and their potential value in cancer therapies, Crit Rev Oncol Hematol, 53, 35, 10.1016/j.critrevonc.2004.09.004 Buijs, 2007, TGF-beta and BMP7 interactions in tumour progression and bone metastasis, Clin Exp Metastasis, 24, 609, 10.1007/s10585-007-9118-2 Guarino, 2007, Epithelial–mesenchymal transition and tumour invasion, Int J Biochem Cell Biol, 39, 2153, 10.1016/j.biocel.2007.07.011 Huber, 2005, Molecular requirements for epithelial–mesenchymal transition during tumor progression, Curr Opin Cell Biol, 17, 548, 10.1016/j.ceb.2005.08.001 Thiery, 2006, Complex networks orchestrate epithelial–mesenchymal transitions, Nat Rev Mol Cell Biol, 7, 131, 10.1038/nrm1835 Trimboli, 2008, Direct evidence for epithelial–mesenchymal transitions in breast cancer, Cancer Res, 68, 937, 10.1158/0008-5472.CAN-07-2148 Jiang, 2000, E-cadherin complex and its abnormalities in human breast cancer, Surg Oncol, 9, 151, 10.1016/S0960-7404(01)00010-X Zschiesche, 1997, Expression of E-cadherin and catenins in invasive mammary carcinomas, Anticancer Res, 17, 561 Jiang, 1996, E-cadherin and its associated protein catenins, cancer invasion and metastasis, Br J Surg, 83, 437, 10.1002/bjs.1800830404 Gottardi, 2001, E-cadherin suppresses cellular transformation by inhibiting beta-catenin signaling in an adhesion-independent manner, J Cell Biol, 153, 1049, 10.1083/jcb.153.5.1049 Stockinger, 2001, E-cadherin regulates cell growth by modulating proliferation-dependent beta-catenin transcriptional activity, J Cell Biol, 154, 1185, 10.1083/jcb.200104036 Cano, 2000, The transcription factor snail controls epithelial–mesenchymal transitions by repressing E-cadherin expression, Nat Cell Biol, 2, 76, 10.1038/35000025 Medici, 2008, Snail and Slug promote epithelial–mesenchymal transition through beta-catenin-T-cell factor-4-dependent expression of transforming growth factor-beta3, Mol Biol Cell, 19, 4875, 10.1091/mbc.E08-05-0506 Peinado, 2007, Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?, Nat Rev Cancer, 7, 415, 10.1038/nrc2131 Thiery, 2002, Epithelial–mesenchymal transitions in tumour progression, Nat Rev Cancer, 2, 442, 10.1038/nrc822 Martin, 2005, Expression of the transcription factors snail, slug, and twist and their clinical significance in human breast cancer, Ann Surg Oncol, 12, 488, 10.1245/ASO.2005.04.010 Rosivatz, 2002, Differential expression of the epithelial–mesenchymal transition regulators snail SIP1, and twist in gastric cancer, Am J Pathol, 161, 1881, 10.1016/S0002-9440(10)64464-1 Yang, 2004, Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis, Cell, 117, 927, 10.1016/j.cell.2004.06.006 Batlle, 2000, The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells, Nat Cell Biol, 2, 84, 10.1038/35000034 Blanco, 2002, Correlation of Snail expression with histological grade and lymph node status in breast carcinomas, Oncogene, 21, 3241, 10.1038/sj.onc.1205416 Qiao, 2010, Epithelial–mesenchymal transition in oral squamous cell carcinoma triggered by transforming growth factor-beta1 is Snail family-dependent and correlates with matrix metalloproteinase-2 and -9 expressions, Int J Oncol, 37, 663 Spano, 2012, Molecular networks that regulate cancer metastasis, Semin Cancer Biol, 22, 234, 10.1016/j.semcancer.2012.03.006 Spano, 2012, Tumor microenvironment: a main actor in the metastasis process, Clin Exp Metastasis, 29, 381, 10.1007/s10585-012-9457-5 Botkjaer, 2012, Targeting tumor cell invasion and dissemination in vivo by an aptamer that inhibits urokinase-type plasminogen activator through a novel multifunctional mechanism, Mol Cancer Res, 10, 1532, 10.1158/1541-7786.MCR-12-0349 Rabbani, 2010, An anti-urokinase plasminogen activator receptor antibody (ATN-658) blocks prostate cancer invasion, migration, growth, and experimental skeletal metastasis in vitro and in vivo, Neoplasia, 12, 778, 10.1593/neo.10296 Kim, 2006, Systemic anti-hepatocyte growth factor monoclonal antibody therapy induces the regression of intracranial glioma xenografts, Clin Cancer Res, 12, 1292, 10.1158/1078-0432.CCR-05-1793 Domanska, 2012, CXCR4 inhibition with AMD3100 sensitizes prostate cancer to docetaxel chemotherapy, Neoplasia, 14, 709, 10.1593/neo.12324 Devine, 2004, Rapid mobilization of CD34+ cells following administration of the CXCR4 antagonist AMD3100 to patients with multiple myeloma and non-Hodgkin's lymphoma, J Clin Oncol, 22, 1095, 10.1200/JCO.2004.07.131 Rubin, 2003, A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors, Proc Natl Acad Sci U S A, 100, 13513, 10.1073/pnas.2235846100 Schittenhelm, 2006, Dasatinib (BMS-354825), a dual SRC/ABL kinase inhibitor, inhibits the kinase activity of wild-type, juxtamembrane, and activation loop mutant KIT isoforms associated with human malignancies, Cancer Res, 66, 473, 10.1158/0008-5472.CAN-05-2050 Spano, 2013, Dipyridamole prevents triple-negative breast-cancer progression, Clin Exp Metastasis, 30, 47, 10.1007/s10585-012-9506-0 Zollo, 2012, Targeting monocyte chemotactic protein-1 synthesis with bindarit induces tumor regression in prostate and breast cancer animal models, Clin Exp Metastasis, 29, 585, 10.1007/s10585-012-9473-5 Noori, 2013, Sclareol reduces CD4+CD25+FoxP3+ Treg cells in a breast cancer model in vivo, Iran J Immunol, 10, 10 Ridolfi, 2013, Low-dose temozolomide before dendritic-cell vaccination reduces (specifically) CD4+CD25++Foxp3+ regulatory T-cells in advanced melanoma patients, J Transl Med, 11, 135, 10.1186/1479-5876-11-135 Chan, 2008, Leukemia stem cells in acute myeloid leukemia, Semin Oncol, 35, 326, 10.1053/j.seminoncol.2008.04.003 Ginestier, 2007, ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome, Cell Stem Cell, 1, 555, 10.1016/j.stem.2007.08.014 Dalerba, 2007, Phenotypic characterization of human colorectal cancer stem cells, Proc Natl Acad Sci U S A, 104, 10158, 10.1073/pnas.0703478104 Al-Hajj, 2003, Prospective identification of tumorigenic breast cancer cells, Proc Natl Acad Sci U S A, 100, 3983, 10.1073/pnas.0530291100 Prince, 2007, Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma, Proc Natl Acad Sci U S A, 104, 973, 10.1073/pnas.0610117104 Clay, 2010, Single-marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase, Head Neck, 32, 1195, 10.1002/hed.21315 Clarke, 2006, Cancer stem cells – perspectives on current status and future directions: AACR Workshop on cancer stem cells, Cancer Res, 66, 9339, 10.1158/0008-5472.CAN-06-3126 Charafe-Jauffret, 2009, Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature, Cancer Res, 69, 1302, 10.1158/0008-5472.CAN-08-2741 Davis, 2010, Metastatic potential of cancer stem cells in head and neck squamous cell carcinoma, Arch Otolaryngol Head Neck Surg, 136, 1260, 10.1001/archoto.2010.219 Chinn, 2014, Cancer stem cells: mediators of tumorigenesis and metastasis in head and neck squamous cell carcinoma, Head Neck Gassmann, 2009, CXCR4 regulates the early extravasation of metastatic tumor cells in vivo, Neoplasia, 11, 651, 10.1593/neo.09272 Hermann, 2007, Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer, Cell Stem Cell, 1, 313, 10.1016/j.stem.2007.06.002 Brabletz, 2005, Opinion: migrating cancer stem cells – an integrated concept of malignant tumour progression, Nat Rev Cancer, 5, 744, 10.1038/nrc1694 Dieter, 2011, Distinct types of tumor-initiating cells form human colon cancer tumors and metastases, Cell Stem Cell, 9, 357, 10.1016/j.stem.2011.08.010 Merlos-Suarez, 2011, The intestinal stem cell signature identifies colorectal cancer stem cells and predicts disease relapse, Cell Stem Cell, 8, 511, 10.1016/j.stem.2011.02.020 Pang, 2010, A subpopulation of CD26+ cancer stem cells with metastatic capacity in human colorectal cancer, Cell Stem Cell, 6, 603, 10.1016/j.stem.2010.04.001 Yang, 2008, Epithelial–mesenchymal transition: at the crossroads of development and tumor metastasis, Dev Cell, 14, 818, 10.1016/j.devcel.2008.05.009 Mani, 2008, The epithelial–mesenchymal transition generates cells with properties of stem cells, Cell, 133, 704, 10.1016/j.cell.2008.03.027 Creighton, 2013, The role of epithelial–mesenchymal transition programming in invasion and metastasis: a clinical perspective, Cancer Manage Res, 5, 187, 10.2147/CMAR.S35171 Jing, 2011, Epithelial–mesenchymal transition in tumor microenvironment, Cell Biosci, 1, 29, 10.1186/2045-3701-1-29 Le, 2008, Tumour–stroma interactions in colorectal cancer: converging on beta-catenin activation and cancer stemness, Br J Cancer, 98, 1886, 10.1038/sj.bjc.6604401 Paget, 1889, The distribution of secondary growths in cancer of the breast, Lancet, 133, 571, 10.1016/S0140-6736(00)49915-0 Buijs, 2009, Osteotropic cancers: from primary tumor to bone, Cancer Lett, 273, 177, 10.1016/j.canlet.2008.05.044 Weilbaecher, 2011, Cancer to bone: a fatal attraction, Nat Rev Cancer, 11, 411, 10.1038/nrc3055 Shiozawa, 2011, Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow, J Clin Invest, 121, 1298, 10.1172/JCI43414 Pecheur, 2002, Integrin alpha(v)beta3 expression confers on tumor cells a greater propensity to metastasize to bone, FASEB J, 16, 1266, 10.1096/fj.01-0911fje Clezardin, 2009, Integrins in bone metastasis formation and potential therapeutic implications, Curr Cancer Drug Targets, 9, 801, 10.2174/156800909789760348 Bauerle, 2011, Cilengitide inhibits progression of experimental breast cancer bone metastases as imaged noninvasively using VCT, MRI and DCE-MRI in a longitudinal in vivo study, Int J Cancer, 128, 2453, 10.1002/ijc.25563 Desgrosellier, 2010, Integrins in cancer: biological implications and therapeutic opportunities, Nat Rev Cancer, 10, 9, 10.1038/nrc2748 Birchmeier, 2003, Met, metastasis, motility and more, Nat Rev Mol Cell Biol, 4, 915, 10.1038/nrm1261 Smith, 2013, Cabozantinib in patients with advanced prostate cancer: results of a phase II randomized discontinuation trial, J Clin Oncol, 31, 412, 10.1200/JCO.2012.45.0494 Garnero, 1998, The collagenolytic activity of cathepsin K is unique among mammalian proteinases, J Biol Chem, 273, 32347, 10.1074/jbc.273.48.32347 Brubaker, 2003, Cathepsin K mRNA and protein expression in prostate cancer progression, J Bone Miner Res, 18, 222, 10.1359/jbmr.2003.18.2.222 Le Gall, 2007, A cathepsin K inhibitor reduces breast cancer induced osteolysis and skeletal tumor burden, Cancer Res, 67, 9894, 10.1158/0008-5472.CAN-06-3940 Jensen, 2010, The cathepsin K inhibitor odanacatib suppresses bone resorption in women with breast cancer and established bone metastases: results of a 4-week, double-blind, randomized, controlled trial, Clin Breast Cancer, 10, 452, 10.3816/CBC.2010.n.059 Liu, 2005, Cross-talk between the interleukin-6 and prostaglandin E(2) signaling systems results in enhancement of osteoclastogenesis through effects on the osteoprotegerin/receptor activator of nuclear factor-{kappa}B (RANK) ligand/RANK system, Endocrinology, 146, 1991, 10.1210/en.2004-1167 Nguyen, 2009, Metastasis: from dissemination to organ-specific colonization, Nat Rev Cancer, 9, 274, 10.1038/nrc2622 Santini, 2011, Receptor activator of NF-kB (RANK) expression in primary tumors associates with bone metastasis occurrence in breast cancer patients, PLoS One, 6, e19234, 10.1371/journal.pone.0019234 Santini, 2011, Expression pattern of receptor activator of NFkappaB (RANK) in a series of primary solid tumors and related bone metastases, J Cell Physiol, 226, 780, 10.1002/jcp.22402 Loser, 2006, Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells, Nat Med, 12, 1372, 10.1038/nm1518 Tan, 2011, Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling, Nature, 470, 548, 10.1038/nature09707 Stopeck, 2010, Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study, J Clin Oncol, 28, 5132, 10.1200/JCO.2010.29.7101 Fizazi, 2011, Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study, Lancet, 377, 813, 10.1016/S0140-6736(10)62344-6 Henry, 2011, Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma, J Clin Oncol, 29, 1125, 10.1200/JCO.2010.31.3304 Smith, 2009, Denosumab in men receiving androgen-deprivation therapy for prostate cancer, N Engl J Med, 361, 745, 10.1056/NEJMoa0809003 Tatarov, 2009, SRC family kinase activity is up-regulated in hormone-refractory prostate cancer, Clin Cancer Res, 15, 3540, 10.1158/1078-0432.CCR-08-1857 Zaidi, 2004, Tyrosine phosphorylation controls Runx2-mediated subnuclear targeting of YAP to repress transcription, EMBO J, 23, 790, 10.1038/sj.emboj.7600073 Chang, 2008, Src family kinase oncogenic potential and pathways in prostate cancer as revealed by AZD0530, Oncogene, 27, 6365, 10.1038/onc.2008.250 Yang, 2009, Aberrant activation of androgen receptor in a new neuropeptide-autocrine model of androgen-insensitive prostate cancer, Cancer Res, 69, 151, 10.1158/0008-5472.CAN-08-0442 de Vries, 2009, The Src inhibitor AZD0530 reversibly inhibits the formation and activity of human osteoclasts, Mol Cancer Res, 7, 476, 10.1158/1541-7786.MCR-08-0219 Spencer, 2006, Wnt signalling in osteoblasts regulates expression of the receptor activator of NFkappaB ligand and inhibits osteoclastogenesis in vitro, J Cell Sci, 119, 1283, 10.1242/jcs.02883 Yaccoby, 2007, Antibody-based inhibition of DKK1 suppresses tumor-induced bone resorption and multiple myeloma growth in vivo, Blood, 109, 2106, 10.1182/blood-2006-09-047712 Wang, 2015, Broad targeting of angiogenesis for cancer prevention and therapy, Semin Cancer Biol, 10.1016/j.semcancer.2015.01.001 Edge, 2009 Xi, 2005, Molecular staging of lymph nodes from patients with esophageal adenocarcinoma, Clin Cancer Res, 11, 1099, 10.1158/1078-0432.1099.11.3 McGuill, 2008, The prognostic impact of occult lymph node metastasis in cancer of the esophagus or esophago-gastric junction: systematic review and meta-analysis, Dis Esophagus, 21, 236, 10.1111/j.1442-2050.2007.00765.x Scheuemann, 2001, Cytokeratins and other sensitive markers for esophageal cancer and metastases, Dis Esophagus, 14, 85, 10.1046/j.1442-2050.2001.00161.x Bonavina, 1999, Lymph node micrometastases in patients with adenocarcinoma of the esophagogastric junction, J Gastrointest Surg, 3, 468, 10.1016/S1091-255X(99)80099-7 Heeren, 2005, Prognostic value of nodal micrometastases in patients with cancer of the gastro-oesophageal junction, Eur J Surg Oncol, 31, 270, 10.1016/j.ejso.2004.12.001 Komukai, 2000, Significance of immunohistochemically demonstrated micrometastases to lymph nodes in esophageal cancer with histologically negative nodes, Surgery, 127, 40, 10.1067/msy.2000.102754 Doki, 2002, Cytokeratin deposits in lymph nodes show distinct clinical significance from lymph node micrometastasis in human esophageal cancers, J Surg Res, 107, 75, 10.1016/S0022-4804(02)96506-6 Mueller, 2000, Frequency and clinical impact of lymph node micrometastasis and tumor cell microinvolvement in patients with adenocarcinoma of the esophagogastric junction, Cancer, 89, 1874, 10.1002/1097-0142(20001101)89:9<1874::AID-CNCR2>3.3.CO;2-D Schurr, 2006, Lymphatic spread and microinvolvement in adenocarcinoma of the esophago-gastric junction, J Surg Oncol, 94, 307, 10.1002/jso.20582 Izbicki, 1997, Prognostic value of immunohistochemically identifiable tumor cells in lymph nodes of patients with completely resected esophageal cancer, N Engl J Med, 337, 1188, 10.1056/NEJM199710233371702 MacGuill, 2007, Isolated tumour cells in pathological node-negative lymph nodes adversely affect prognosis in cancer of the oesophagus or oesophagogastric junction, J Clin Pathol, 60, 1108, 10.1136/jcp.2006.044149 Koenig, 2009, Strong impact of micrometastatic tumor cell load in patients with esophageal carcinoma, Ann Surg Oncol, 16, 454, 10.1245/s10434-008-0169-7 Natsugoe, 1998, Micrometastasis and tumor cell microinvolvement of lymph nodes from esophageal squamous cell carcinoma: frequency, associated tumor characteristics, and impact on prognosis, Cancer, 83, 858, 10.1002/(SICI)1097-0142(19980901)83:5<858::AID-CNCR9>3.0.CO;2-E Yekebas, 2006, Effectiveness of radical en-bloc-esophagectomy compared to transhiatal esophagectomy in squamous cell cancer of the esophagus is influenced by nodal micrometastases, J Surg Oncol, 93, 541, 10.1002/jso.20544 Glickman, 1999, The prognostic significance of lymph node micrometastasis in patients with esophageal carcinoma, Cancer, 85, 769, 10.1002/(SICI)1097-0142(19990215)85:4<769::AID-CNCR3>3.0.CO;2-I Vazquez-Sequeiros, 2002, Occult lymph node metastases as a predictor of tumor relapse in patients with node-negative esophageal carcinoma, Gastroenterology, 122, 1815, 10.1053/gast.2002.33665 Waterman, 2004, The prognostic importance of immunohistochemically detected node metastases in resected esophageal adenocarcinoma, Ann Thorac Surg, 78, 1161, 10.1016/j.athoracsur.2004.04.045 Zingg, 2009, Prognostic influence of immunohistochemically detected lymph node micrometastasis and histological subtype in pN0 oesophageal cancer, Eur J Surg Oncol, 35, 593, 10.1016/j.ejso.2008.12.001 Sato, 2001, Lymph node micrometastasis and prognosis in patients with oesophageal squamous cell carcinoma, Br J Surg, 88, 426, 10.1046/j.1365-2168.2001.01687.x Thompson, 2010, Isolated tumor cells in esophageal cancer: implications for the surgeon and the pathologist, Ann Surg, 252, 299, 10.1097/SLA.0b013e3181e61e15 Horstmann, 2004, Significance of isolated tumor cells in lymph nodes among gastric cancer patients, J Cancer Res Clin Oncol, 130, 733, 10.1007/s00432-004-0609-0 Scheunemann, 2009, Occult disseminated tumor cells in lymph nodes of patients with gastric carcinoma: a critical appraisal of assessment and relevance, Langenbecks Arch Surg, 394, 105, 10.1007/s00423-008-0369-4 Scheri, 2007, Isolated tumor cells in the sentinel node affect long-term prognosis of patients with melanoma, Ann Surg Oncol, 14, 2861, 10.1245/s10434-007-9472-y de Boer, 2009, Micrometastases or isolated tumor cells and the outcome of breast cancer, N Engl J Med, 361, 653, 10.1056/NEJMoa0904832 Mittendorf, 2008, Lymphovascular invasion and lobular histology are associated with increased incidence of isolated tumor cells in sentinel lymph nodes from early-stage breast cancer patients, Ann Surg Oncol, 15, 3369, 10.1245/s10434-008-0153-2 Ryden, 2007, Determination of sentinel lymph node (SLN) status in primary breast cancer by prospective use of immunohistochemistry increases the rate of micrometastases and isolated tumour cells: analysis of 174 patients after SLN biopsy, Eur J Surg Oncol, 33, 33, 10.1016/j.ejso.2006.11.007 Li, 2008, The location of small tumor deposits in the SLN predicts Non-SLN macrometastases in breast cancer patients, Eur J Surg Oncol, 34, 857, 10.1016/j.ejso.2007.07.009 Bukholm, 2003, Presence of isolated tumour cells in mesenteric lymph nodes predicts poor prognosis in patients with stage II colon cancer, Eur J Surg Oncol, 29, 862, 10.1016/j.ejso.2003.09.007 Mescoli, 2006, High prevalence of isolated tumour cells in regional lymph nodes from pN0 colorectal cancer, J Clin Pathol, 59, 870, 10.1136/jcp.2005.036350 Rosenberg, 2004, Prognostic evaluation and review of immunohistochemically detected disseminated tumor cells in peritumoral lymph nodes of patients with pN0 colorectal cancer, Int J Colorectal Dis, 19, 430, 10.1007/s00384-003-0559-z Passlick, 1994, Immunohistochemical assessment of individual tumor cells in lymph nodes of patients with non-small-cell lung cancer, J Clin Oncol, 12, 1827, 10.1200/JCO.1994.12.9.1827 Klein, 2009, Lessons from an aggressive cancer: evolutionary dynamics in esophageal carcinoma, Cancer Res, 69, 5285, 10.1158/0008-5472.CAN-08-4586 Morton, 1992, Technical details of intraoperative lymphatic mapping for early stage melanoma, Arch Surg, 127, 392, 10.1001/archsurg.1992.01420040034005 Thompson, 2011, Sentinel lymph node biopsy in esophageal cancer: should it be standard of care?, J Gastrointest Surg, 15, 1762, 10.1007/s11605-011-1634-3 Thierry, 2009, Drug nanocarriers and functional nanoparticles: applications in cancer therapy, Curr Drug Deliv, 6, 391, 10.2174/156720109789000474 Liu, 2013, Immunospecific targeting of CD45 expressing lymphoid cells: towards improved detection agents of the sentinel lymph node, Cancer Lett, 328, 271, 10.1016/j.canlet.2012.09.024 Harisinghani, 2003, Noninvasive detection of clinically occult lymph-node metastases in prostate cancer, N Engl J Med, 348, 2491, 10.1056/NEJMoa022749 Tafreshi, 2012, Noninvasive detection of breast cancer lymph node metastasis using carbonic anhydrases IX and XII targeted imaging probes, Clin Cancer Res, 18, 207, 10.1158/1078-0432.CCR-11-0238 Tafreshi, 2010, A mammaglobin-A targeting agent for noninvasive detection of breast cancer metastasis in lymph nodes, Cancer Res, 71, 1050, 10.1158/0008-5472.CAN-10-3091 Xie, 2009, Drug delivery to the lymphatic system: importance in future cancer diagnosis and therapies, Expert Opin Drug Deliv, 6, 785, 10.1517/17425240903085128 Liggins, 2000, Paclitaxel loaded poly(l-lactic acid) microspheres for the prevention of intraperitoneal carcinomatosis after a surgical repair and tumor cell spill, Biomaterials, 21, 1959, 10.1016/S0142-9612(00)00080-6 Garrison, 1986, Malignant ascites: clinical and experimental observations, Ann Surg, 203, 644, 10.1097/00000658-198606000-00009 Cunliffe, 1989, Gastrointestinal malignancy: rationale for adjuvant therapy using early postoperative intraperitoneal chemotherapy, Br J Surg, 76, 1082, 10.1002/bjs.1800761030 Amadori, 1997, Ovarian cancer: natural history and metastatic pattern, Front Biosci, 2, g8 Cintron, 1996, Colorectal cancer and peritoneal carcinomatosis, Semin Surg Oncol, 12, 267, 10.1002/(SICI)1098-2388(199607/08)12:4<267::AID-SSU6>3.0.CO;2-3 Marutsuka, 2003, Mechanisms of peritoneal metastasis after operation for non-serosa-invasive gastric carcinoma: an ultrarapid detection system for intraperitoneal free cancer cells and a prophylactic strategy for peritoneal metastasis, Clin Cancer Res, 9, 678 del Castillo, 1993, Peritoneal metastases in pancreatic carcinoma, Hepatogastroenterology, 40, 430 Sadeghi, 2000, Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study, Cancer, 88, 358, 10.1002/(SICI)1097-0142(20000115)88:2<358::AID-CNCR16>3.0.CO;2-O Jones, 1995, Hyaluronic acid secreted by mesothelial cells: a natural barrier to ovarian cancer cell adhesion, Clin Exp Metastasis, 13, 373, 10.1007/BF00121913 Lv, 2012, TGF-beta1 induces peritoneal fibrosis by activating the Smad2 pathway in mesothelial cells and promotes peritoneal carcinomatosis, Int J Mol Med, 29, 373 Watanabe, 2012, Production of IL1-beta by ovarian cancer cells induces mesothelial cell beta1-integrin expression facilitating peritoneal dissemination, J Ovarian Res, 5, 7, 10.1186/1757-2215-5-7 Chaffer, 2011, A perspective on cancer cell metastasis, Science, 331, 1559, 10.1126/science.1203543 Ardalan, 2010, A phase I study of 5-fluorouracil/leucovorin and arsenic trioxide for patients with refractory/relapsed colorectal carcinoma, Clin Cancer Res, 16, 3019, 10.1158/1078-0432.CCR-09-2590 Cragg, 2013, Natural products: a continuing source of novel drug leads, Biochim Biophys Acta, 1830, 3670, 10.1016/j.bbagen.2013.02.008 Singh, 2008, Silibinin inhibits established prostate tumor growth, progression, invasion, and metastasis and suppresses tumor angiogenesis and epithelial–mesenchymal transition in transgenic adenocarcinoma of the mouse prostate model mice, Clin Cancer Res, 14, 7773, 10.1158/1078-0432.CCR-08-1309 Dastpeyman, 2012, Inhibition of silibinin on migration and adhesion capacity of human highly metastatic breast cancer cell line, MDA-MB-231, by evaluation of beta1-integrin and downstream molecules, Cdc42, Raf-1 and D4GDI, Med Oncol, 29, 2512, 10.1007/s12032-011-0113-8 Kauntz, 2012, The flavonolignan silibinin potentiates TRAIL-induced apoptosis in human colon adenocarcinoma and in derived TRAIL-resistant metastatic cells, Apoptosis, 17, 797, 10.1007/s10495-012-0731-4 Yousefi, 2012, Therapeutic efficacy of silibinin on human neuroblastoma cells: Akt and NF-kappaB expressions may play an important role in silibinin-induced response, Neurochem Res, 37, 2053, 10.1007/s11064-012-0827-9 Deep, 2012, Angiopreventive efficacy of pure flavonolignans from milk thistle extract against prostate cancer: targeting VEGF-VEGFR signaling, PLoS One, 7, e34630, 10.1371/journal.pone.0034630 Ye, 2012, Impact of Yangzheng Xiaoji on the adhesion and migration of human cancer cells: the role of the AKT signalling pathway, Anticancer Res, 32, 2537 Jiang, 2012, Inhibitory effects of Yangzheng Xiaoji on angiogenesis and the role of the focal adhesion kinase pathway, Int J Oncol, 41, 1635, 10.3892/ijo.2012.1627 Jiang, 2013, Antitumour effects of Yangzheng Xiaoji in human osteosarcoma: the pivotal role of focal adhesion kinase signalling, Oncol Rep, 30, 1405, 10.3892/or.2013.2586 Kohno, 2008, Protein-tyrosine kinase CAKbeta/PYK2 is activated by binding Ca2+/calmodulin to FERM F2 alpha2 helix and thus forming its dimer, Biochem J, 410, 513, 10.1042/BJ20070665 Gilmore, 1996, Inhibition of focal adhesion kinase (FAK) signaling in focal adhesions decreases cell motility and proliferation, Mol Biol Cell, 7, 1209, 10.1091/mbc.7.8.1209 Cai, 2006, Decreased pigment epithelium-derived factor expression in human breast cancer progression, Clin Cancer Res, 12, 3510, 10.1158/1078-0432.CCR-06-0094 Ochiai, 2012, Phosphodiesterase inhibitors: Part 3. Design, synthesis and structure-activity relationships of dual PDE3/4-inhibitory fused bicyclic heteroaromatic-dihydropyridazinones with anti-inflammatory and bronchodilatory activity, Bioorg Med Chem, 20, 1644, 10.1016/j.bmc.2012.01.033 Weng, 2012, Flavonoids, a ubiquitous dietary phenolic subclass, exert extensive in vitro anti-invasive and in vivo anti-metastatic activities, Cancer Metastasis Rev, 31, 323, 10.1007/s10555-012-9347-y Shu, 2010, Phytochemicals: cancer chemoprevention and suppression of tumor onset and metastasis, Cancer Metastasis Rev, 29, 483, 10.1007/s10555-010-9239-y Massague, 2008, TGFbeta in Cancer, Cell, 134, 215, 10.1016/j.cell.2008.07.001 Roberts, 2003, The two faces of transforming growth factor beta in carcinogenesis, Proc Natl Acad Sci U S A, 100, 8621, 10.1073/pnas.1633291100 Akhurst, 2001, TGF-beta signaling in cancer – a double-edged sword, Trends Cell Biol, 11, S44 Feng, 2005, Specificity and versatility in tgf-beta signaling through Smads, Annu Rev Cell Dev Biol, 21, 659, 10.1146/annurev.cellbio.21.022404.142018 Calone, 2012, Inhibition of TGFbeta signaling and its implications in anticancer treatments, Exp Oncol, 34, 9 Hau, 2007, Inhibition of TGF-beta2 with AP 12009 in recurrent malignant gliomas: from preclinical to phase I/II studies, Oligonucleotides, 17, 201, 10.1089/oli.2006.0053 Bogdahn, 2011, Targeted therapy for high-grade glioma with the TGF-beta2 inhibitor trabedersen: results of a randomized and controlled phase IIb study, Neuro Oncol, 13, 132, 10.1093/neuonc/noq142 Zubeldia, 2013, Epithelial to mesenchymal transition and cancer stem cell phenotypes leading to liver metastasis are abrogated by the novel TGFbeta1-targeting peptides P17 and P144, Exp Cell Res, 319, 12, 10.1016/j.yexcr.2012.11.004 Lahn, 2005, TGF-beta inhibitors for the treatment of cancer, Expert Opin Investig Drugs, 14, 629, 10.1517/13543784.14.6.629 Akhurst, 2006, Large- and small-molecule inhibitors of transforming growth factor-beta signaling, Curr Opin Investig Drugs, 7, 513 Bonafoux, 2009, Strategies for TGF-beta modulation: a review of recent patents, Expert Opin Ther Pat, 19, 1759, 10.1517/13543770903397400 Nagaraj, 2010, Targeting the transforming growth factor-beta signaling pathway in human cancer, Expert Opin Investig Drugs, 19, 77, 10.1517/13543780903382609 Hjelmeland, 2004, SB-431542, a small molecule transforming growth factor-beta-receptor antagonist, inhibits human glioma cell line proliferation and motility, Mol Cancer Ther, 3, 737, 10.1158/1535-7163.737.3.6 Halder, 2005, A specific inhibitor of TGF-beta receptor kinase, SB-431542, as a potent antitumor agent for human cancers, Neoplasia, 7, 509, 10.1593/neo.04640 Simon, 2011, A phase I study of tasisulam sodium (LY573636 sodium), a novel anticancer compound in patients with refractory solid tumors, Cancer Chemother Pharmacol, 68, 1233, 10.1007/s00280-011-1593-0 Kirkwood, 2011, A phase 2 study of tasisulam sodium (LY573636 sodium) as second-line treatment for patients with unresectable or metastatic melanoma, Cancer, 117, 4732, 10.1002/cncr.26068 Uhl, 2004, SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo, Cancer Res, 64, 7954, 10.1158/0008-5472.CAN-04-1013 Ge, 2006, Inhibition of growth and metastasis of mouse mammary carcinoma by selective inhibitor of transforming growth factor-beta type I receptor kinase in vivo, Clin Cancer Res, 12, 4315, 10.1158/1078-0432.CCR-06-0162 Gaspar, 2007, Inhibition of transforming growth factor beta signaling reduces pancreatic adenocarcinoma growth and invasiveness, Mol Pharmacol, 72, 152, 10.1124/mol.106.029025 Mohammad, 2011, TGF-beta-RI kinase inhibitor SD-208 reduces the development and progression of melanoma bone metastases, Cancer Res, 71, 175, 10.1158/0008-5472.CAN-10-2651 Suzuki, 2007, A novel small-molecule inhibitor of transforming growth factor beta type I receptor kinase (SM16) inhibits murine mesothelioma tumor growth in vivo and prevents tumor recurrence after surgical resection, Cancer Res, 67, 2351, 10.1158/0008-5472.CAN-06-2389 Rausch, 2009, An orally active small molecule TGF-beta receptor I antagonist inhibits the growth of metastatic murine breast cancer, Anticancer Res, 29, 2099 Garrison, 2012, The small molecule TGF-beta signaling inhibitor SM16 synergizes with agonistic OX40 antibody to suppress established mammary tumors and reduce spontaneous metastasis, Cancer Immunol Immunother, 61, 511, 10.1007/s00262-011-1119-y Tran, 2007, Inhibiting TGF-beta signaling restores immune surveillance in the SMA-560 glioma model, Neuro Oncol, 9, 259, 10.1215/15228517-2007-010 Fang, 2013, Inhibition of breast cancer metastases by a novel inhibitor of TGFbeta receptor 1, J Natl Cancer Inst, 105, 47, 10.1093/jnci/djs485 Yingling, 2004, Development of TGF-beta signalling inhibitors for cancer therapy, Nat Rev Drug Discov, 3, 1011, 10.1038/nrd1580 Bhola, 2013, TGF-beta inhibition enhances chemotherapy action against triple-negative breast cancer, J Clin Invest, 123, 1348, 10.1172/JCI65416 Zhang, 2009, Targeting transforming growth factor-beta signaling in liver metastasis of colon cancer, Cancer Lett, 277, 114, 10.1016/j.canlet.2008.11.035 Melisi, 2008, LY2109761, a novel transforming growth factor beta receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis, Mol Cancer Ther, 7, 829, 10.1158/1535-7163.MCT-07-0337 Ganapathy, 2010, Targeting the transforming growth factor-beta pathway inhibits human basal-like breast cancer metastasis, Mol Cancer, 9, 122, 10.1186/1476-4598-9-122 Fransvea, 2008, Blocking transforming growth factor-beta up-regulates E-cadherin and reduces migration and invasion of hepatocellular carcinoma cells, Hepatology, 47, 1557, 10.1002/hep.22201 Fransvea, 2009, Targeting transforming growth factor (TGF)-betaRI inhibits activation of beta1 integrin and blocks vascular invasion in hepatocellular carcinoma, Hepatology, 49, 839, 10.1002/hep.22731 Fransvea, 2011, Kinase activation profile associated with TGF-beta-dependent migration of HCC cells: a preclinical study, Cancer Chemother Pharmacol, 68, 79, 10.1007/s00280-010-1459-x Mazzocca, 2009, Inhibition of transforming growth factor beta receptor I kinase blocks hepatocellular carcinoma growth through neo-angiogenesis regulation, Hepatology, 50, 1140, 10.1002/hep.23118 Mazzocca, 2010, Down-regulation of connective tissue growth factor by inhibition of transforming growth factor beta blocks the tumor-stroma cross-talk and tumor progression in hepatocellular carcinoma, Hepatology, 51, 523, 10.1002/hep.23285 Zhang, 2011, Trimodal glioblastoma treatment consisting of concurrent radiotherapy, temozolomide, and the novel TGF-beta receptor I kinase inhibitor LY2109761, Neoplasia, 13, 537, 10.1593/neo.11258 Connolly, 2011, Outgrowth of drug-resistant carcinomas expressing markers of tumor aggression after long-term TbetaRI/II kinase inhibition with LY2109761, Cancer Res, 71, 2339, 10.1158/0008-5472.CAN-10-2941 Ungefroren, 2011, The Src family kinase inhibitors PP2 and PP1 block TGF-beta1-mediated cellular responses by direct and differential inhibition of type I and type II TGF-beta receptors, Curr Cancer Drug Targets, 11, 524, 10.2174/156800911795538075 Yakymovych, 2002, Inhibition of transforming growth factor-beta signaling by low molecular weight compounds interfering with ATP- or substrate-binding sites of the TGF beta type I receptor kinase, Biochemistry, 41, 11000, 10.1021/bi025936u Apte, 2004, Targeting the platelet-derived growth factor receptor in antivascular therapy for human ovarian carcinoma, Clin Cancer Res, 10, 897, 10.1158/1078-0432.CCR-1151-3 Heinrich, 2000, Inhibition of C-kit receptor tyrosine kinase activity by STI 571, a selective tyrosine kinase inhibitor, Blood, 96, 925, 10.1182/blood.V96.3.925 Shrimali, 2010, Antiangiogenic agents can increase lymphocyte infiltration into tumor and enhance the effectiveness of adoptive immunotherapy of cancer, Cancer Res, 70, 6171, 10.1158/0008-5472.CAN-10-0153 Manzoni, 2010, Immunological effects of bevacizumab-based treatment in metastatic colorectal cancer, Oncology, 79, 187, 10.1159/000320609 Zhang, 2004, Inhibition of both the autocrine and the paracrine growth of human leukemia with a fully human antibody directed against vascular endothelial growth factor receptor 2, Leuk Lymphoma, 45, 1887, 10.1080/10428190410001712225 Vajkoczy, 2000, Targeting angiogenesis inhibits tumor infiltration and expression of the pro-invasive protein SPARC, Int J Cancer, 87, 261, 10.1002/1097-0215(20000715)87:2<261::AID-IJC18>3.0.CO;2-6 Nakabayashi, 2010, Anti-invasive and antiangiogenic effects of MMI-166 on malignant glioma cells, BMC Cancer, 10, 339, 10.1186/1471-2407-10-339 Chiappori, 2007, A phase I pharmacokinetic and pharmacodynamic study of s-3304, a novel matrix metalloproteinase inhibitor, in patients with advanced and refractory solid tumors, Clin Cancer Res, 13, 2091, 10.1158/1078-0432.CCR-06-1586 Burgess, 2006, Fully human monoclonal antibodies to hepatocyte growth factor with therapeutic potential against hepatocyte growth factor/c-Met-dependent human tumors, Cancer Res, 66, 1721, 10.1158/0008-5472.CAN-05-3329 Van Cutsem, 2014, Randomized phase Ib/II trial of rilotumumab or ganitumab with panitumumab versus panitumumab alone in patients with wild-type KRAS metastatic colorectal cancer, Clin Cancer Res, 20, 4240, 10.1158/1078-0432.CCR-13-2752 Park, 2010, The therapeutic effect of anti-HER2/neu antibody depends on both innate and adaptive immunity, Cancer Cell, 18, 160, 10.1016/j.ccr.2010.06.014 Botta, 2012, Immune-modulating effects of the newest cetuximab-based chemoimmunotherapy regimen in advanced colorectal cancer patients, J Immunother, 35, 440, 10.1097/CJI.0b013e31825943aa Loo, 2012, Development of an Fc-enhanced anti-B7-H3 monoclonal antibody with potent antitumor activity, Clin Cancer Res, 18, 3834, 10.1158/1078-0432.CCR-12-0715 Veltman, 2010, COX-2 inhibition improves immunotherapy and is associated with decreased numbers of myeloid-derived suppressor cells in mesothelioma, Celecoxib influences MDSC function, BMC Cancer, 10, 464, 10.1186/1471-2407-10-464 Vincent, 2010, 5-Fluorouracil selectively kills tumor-associated myeloid-derived suppressor cells resulting in enhanced T cell-dependent antitumor immunity, Cancer Res, 70, 3052, 10.1158/0008-5472.CAN-09-3690 Iclozan, 2013, Therapeutic regulation of myeloid-derived suppressor cells and immune response to cancer vaccine in patients with extensive stage small cell lung cancer, Cancer Immunol Immunother, 62, 909, 10.1007/s00262-013-1396-8 Lee, 2013, Combined aberrant expression of E-cadherin and S100A4, but not beta-catenin is associated with disease-free survival and overall survival in colorectal cancer patients, Diagn Pathol, 8, 99, 10.1186/1746-1596-8-99 Gonzalez, 2011, Histone methyltransferase EZH2 induces Akt-dependent genomic instability and BRCA1 inhibition in breast cancer, Cancer Res, 71, 2360, 10.1158/0008-5472.CAN-10-1933 Wang, 2007, Eriocalyxin B induces apoptosis of t(8;21) leukemia cells through NF-kappaB and MAPK signaling pathways and triggers degradation of AML1-ETO oncoprotein in a caspase-3-dependent manner, Cell Death Differ, 14, 306, 10.1038/sj.cdd.4401996 Becker-Weimann, 2013, NFkB disrupts tissue polarity in 3D by preventing integration of microenvironmental signals, Oncotarget, 4, 2010, 10.18632/oncotarget.1451 Vousden, 2009, Partners in death: a role for p73 and NF-kB in promoting apoptosis, Aging (Albany NY), 1, 275, 10.18632/aging.100033 Dong, 2012, E-cadherin promotes proliferation of human ovarian cancer cells in vitro via activating MEK/ERK pathway, Acta Pharmacol Sin, 33, 817, 10.1038/aps.2012.30 Junxia, 2010, Double strand RNA-guided endogeneous E-cadherin up-regulation induces the apoptosis and inhibits proliferation of breast carcinoma cells in vitro and in vivo, Cancer Sci, 101, 1790, 10.1111/j.1349-7006.2010.01594.x Shin, 2011, Anti-invasive activities of anthocyanins through modulation of tight junctions and suppression of matrix metalloproteinase activities in HCT-116 human colon carcinoma cells, Oncol Rep, 25, 567 Hong, 2013, Bufalin prevents the migration and invasion of T24 bladder carcinoma cells through the inactivation of matrix metalloproteinases and modulation of tight junctions, Int J Oncol, 42, 277, 10.3892/ijo.2012.1683 Jiang, 2011, Ganodermanontriol (GDNT) exerts its effect on growth and invasiveness of breast cancer cells through the down-regulation of CDC20 and uPA, Biochem Biophys Res Commun, 415, 325, 10.1016/j.bbrc.2011.10.055 Zhang, 2011, Activation of urokinase plasminogen activator and its receptor axis is essential for macrophage infiltration in a prostate cancer mouse model, Neoplasia, 13, 23, 10.1593/neo.10728 Chen, 2013, Glycyrrhiza polysaccharide induces apoptosis and inhibits proliferation of human hepatocellular carcinoma cells by blocking PI3K/AKT signal pathway, Tumour Biol, 34, 1381, 10.1007/s13277-013-0746-7 Zhang, 2013, Knockdown of DEPTOR inhibits cell proliferation and increases chemosensitivity to melphalan in human multiple myeloma RPMI-8226 cells via inhibiting PI3K/AKT activity, J Int Med Res, 41, 584, 10.1177/0300060513480920 Liu, 2012, Effect of FAK, DLC-1 gene expression on OVCAR-3 proliferation, Mol Biol Rep, 39, 10665, 10.1007/s11033-012-1956-6 Maritz, 2011, Inhibition of AP-1 suppresses cervical cancer cell proliferation and is associated with p21 expression, Biol Chem, 392, 439, 10.1515/bc.2011.036 Connelly, 2011, Inhibition of NF-kappa B activity in mammary epithelium increases tumor latency and decreases tumor burden, Oncogene, 30, 1402, 10.1038/onc.2010.521 Li, 2011, Fisetin, a dietary flavonoid, induces cell cycle arrest and apoptosis through activation of p53 and inhibition of NF-kappa B pathways in bladder cancer cells, Basic Clin Pharmacol Toxicol, 108, 84, 10.1111/j.1742-7843.2010.00613.x Harikumar, 2010, Sesamin manifests chemopreventive effects through the suppression of NF-kappa B-regulated cell survival, proliferation, invasion, and angiogenic gene products, Mol Cancer Res, 8, 751, 10.1158/1541-7786.MCR-09-0565 Xu, 2013, Propofol suppresses proliferation, invasion and angiogenesis by down-regulating ERK-VEGF/MMP-9 signaling in Eca-109 esophageal squamous cell carcinoma cells, Eur Rev Med Pharmacol Sci, 17, 2486 Ma, 2013, RNAi-mediated knockdown of relaxin decreases in vitro proliferation and invasiveness of osteosarcoma MG-63 cells by inhibition of MMP-9, Eur Rev Med Pharmacol Sci, 17, 1102 Wu, 2013, Silibinin inhibits beta-catenin/ZEB1 signaling and suppresses bladder cancer metastasis via dual-blocking epithelial–mesenchymal transition and stemness, Cell Signal, 25, 2625, 10.1016/j.cellsig.2013.08.028 Ono, 2012, Direct inhibition of the transforming growth factor-beta pathway by protein-bound polysaccharide through inactivation of Smad2 signaling, Cancer Sci, 103, 317, 10.1111/j.1349-7006.2011.02133.x Kleer, 2001, Persistent E-cadherin expression in inflammatory breast cancer, Mod Pathol, 14, 458, 10.1038/modpathol.3880334 Rubin, 2001, E-cadherin expression in prostate cancer: a broad survey using high-density tissue microarray technology, Hum Pathol, 32, 690, 10.1053/hupa.2001.25902 Fasano, 2011, Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancer, Physiol Rev, 91, 151, 10.1152/physrev.00003.2008 Shiozaki, 2012, Claudin 1 mediates TNFalpha-induced gene expression and cell migration in human lung carcinoma cells, PLoS One, 7, e38049, 10.1371/journal.pone.0038049 Dong, 2013, CXCR2-driven ovarian cancer progression involves upregulation of proinflammatory chemokines by potentiating NF-kappaB activation via EGFR-transactivated Akt signaling, PLOS ONE, 8, e83789, 10.1371/journal.pone.0083789 Smith, 2013, Interleukin-6 and oncostatin-M synergize with the PI3K/AKT pathway to promote aggressive prostate malignancy in mouse and human tissues, Mol Cancer Res, 11, 1159, 10.1158/1541-7786.MCR-13-0238 Liu, 2014, AKT hyperactivation confers a Th1 phenotype in thymic Treg cells deficient in TGF-beta receptor II signaling, Eur J Immunol, 44, 521, 10.1002/eji.201243291 Mon, 2006, FAK signaling in neoplastic disorders: a linkage between inflammation and cancer, Ann N Y Acad Sci, 1086, 199, 10.1196/annals.1377.019 Mon, 2009, Inflammation and tumor progression: a lesson from TNF-alpha-dependent FAK signaling in cholangiocarcinoma, Methods Mol Biol, 512, 279, 10.1007/978-1-60327-530-9_15 Kang, 2012, Targeting of noncanonical Wnt5a signaling by AP-1 blocker dominant-negative Jun when it inhibits skin carcinogenesis, Genes Cancer, 3, 37, 10.1177/1947601912448820 Sakurai, 2012, Targeting of TAK1 in inflammatory disorders and cancer, Trends Pharmacol Sci, 33, 522, 10.1016/j.tips.2012.06.007 Vander Broek, 2014, Chemoprevention of head and neck squamous cell carcinoma through inhibition of NF-kappaB signaling, Oral Oncol, 50, 930, 10.1016/j.oraloncology.2013.10.005 Segredo, 1990, Prolonged neuromuscular blockade after long-term administration of vecuronium in two critically ill patients, Anesthesiology, 72, 566, 10.1097/00000542-199003000-00030 O'Sullivan, 2014, Nitric oxide-matrix metaloproteinase-9 interactions: biological and pharmacological significance – NO and MMP-9 interactions, Biochim Biophys Acta, 1843, 603, 10.1016/j.bbamcr.2013.12.006 Salim, 2014, The inflammatory mediator leukotriene D(4) induces subcellular beta-catenin translocation and migration of colon cancer cells, Exp Cell Res, 321, 255, 10.1016/j.yexcr.2013.10.021 Piva, 2013, Role of inflammation in oral carcinogenesis (Part II): CD8, FOXP3, TNF-alpha, TGF-beta and NF-kappaB expression, Oncol Lett, 5, 1909, 10.3892/ol.2013.1302 Yang, 2010, TGFbeta and cancer metastasis: an inflammation link, Cancer Metastasis Rev, 29, 263, 10.1007/s10555-010-9226-3 Georgopoulos, 2010, Differential regulation of growth-promoting signalling pathways by E-cadherin, PLoS One, 5, e13621, 10.1371/journal.pone.0013621 Kantak, 1998, E-cadherin regulates anchorage-independent growth and survival in oral squamous cell carcinoma cells, J Biol Chem, 273, 16953, 10.1074/jbc.273.27.16953 Al Moustafa, 1999, Up-regulation of E-cadherin by an anti-epidermal growth factor receptor monoclonal antibody in lung cancer cell lines, Clin Cancer Res, 5, 681 Tamura, 2008, Megaintestine in claudin-15-deficient mice, Gastroenterology, 134, 523, 10.1053/j.gastro.2007.11.040 Ivina, 2014, Ki-67 and claudin-1 expression in hyperplasia, oral squamous inthraepithelial neoplasia and oral squamous cell carcinoma, Stomatologiia (Mosk), 93, 31 Kennedy, 1997, The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal, Genes Dev, 11, 701, 10.1101/gad.11.6.701 Lai, 2010, Phosphorylation of focal adhesion kinase at Tyr397 in gastric carcinomas and its clinical significance, Am J Pathol, 177, 1629, 10.2353/ajpath.2010.100172 Lazaro, 2013, Targeting focal adhesion kinase in ER+/HER2+ breast cancer improves trastuzumab response, Endocr Relat Cancer, 20, 691, 10.1530/ERC-13-0019 Chung, 1999, Inhibition of activator protein 1 activity and cell growth by purified green tea and black tea polyphenols in H-ras-transformed cells: structure–activity relationship and mechanisms involved, Cancer Res, 59, 4610 Li, 2001, Re: Role of transforming growth factor-beta signaling in cancer, J Natl Cancer Inst, 93, 555, 10.1093/jnci/93.7.555 Hwang, 2011, Suppression of EGF-induced tumor cell migration and matrix metalloproteinase-9 expression by capsaicin via the inhibition of EGFR-mediated FAK/Akt, PKC/Raf/ERK, p38 MAPK, and AP-1 signaling, Mol Nutr Food Res, 55, 594, 10.1002/mnfr.201000292 Hallett, 2013, Anti-matrix metalloproteinase-9 DNAzyme decreases tumor growth in the MMTV-PyMT mouse model of breast cancer, Breast Cancer Res, 15, R12, 10.1186/bcr3385 Sanchez-Tillo, 2014, The EMT activator ZEB1 promotes tumor growth and determines differential response to chemotherapy in mantle cell lymphoma, Cell Death Differ, 21, 247, 10.1038/cdd.2013.123 Jakowlew, 2006, Transforming growth factor-beta in cancer and metastasis, Cancer Metastasis Rev, 25, 435, 10.1007/s10555-006-9006-2 Yoo, 1999, TGF-beta-induced cell-cycle arrest through the p21(WAF1/CIP1)-G1 cyclin/Cdks-p130 pathway in gastric-carcinoma cells, Int J Cancer, 83, 512, 10.1002/(SICI)1097-0215(19991112)83:4<512::AID-IJC13>3.0.CO;2-Z Hocevar, 1998, Mechanisms of TGF-beta-induced cell cycle arrest, Miner Electrolyte Metab, 24, 131, 10.1159/000057360 Rosano, 2011, Acquisition of chemoresistance and EMT phenotype is linked with activation of the endothelin A receptor pathway in ovarian carcinoma cells, Clin Cancer Res, 17, 2350, 10.1158/1078-0432.CCR-10-2325 Mima, 2005, Induction of claudin-4 by nonsteroidal anti-inflammatory drugs and its contribution to their chemopreventive effect, Cancer Res, 65, 1868, 10.1158/0008-5472.CAN-04-2770 Paland, 2013, Urokinase-type plasminogen activator (uPA) modulates monocyte-to-macrophage differentiation and prevents Ox-LDL-induced macrophage apoptosis, Atherosclerosis, 231, 29, 10.1016/j.atherosclerosis.2013.08.016 Cassinelli, 2013, Targeting the Akt kinase to modulate survival, invasiveness and drug resistance of cancer cells, Curr Med Chem, 20, 1923, 10.2174/09298673113209990106 Andjilani, 2006, Down-regulation of FAK and IAPs by laminin during cisplatin-induced apoptosis in testicular germ cell tumors, Int J Oncol, 28, 535 Portanova, 2013, Notch inhibition restores TRAIL-mediated apoptosis via AP1-dependent upregulation of DR4 and DR5 TRAIL receptors in MDA-MB-231 breast cancer cells, Int J Oncol, 43, 121, 10.3892/ijo.2013.1945 Wang, 2010, Effect of NF-kappaB signaling on apoptosis in chronic inflammation-associated carcinogenesis, Curr Cancer Drug Targets, 10, 593, 10.2174/156800910791859425 Sweeney, 2002, Clin Cancer Res, 8, 2714 Zimmerman, 2013, Activation of Wnt/beta-catenin signaling increases apoptosis in melanoma cells treated with trail, PLOS ONE, 8, e69593, 10.1371/journal.pone.0069593 Kortlever, 2006, Senescence, wound healing and cancer: the PAI-1 connection, Cell Cycle, 5, 2697, 10.4161/cc.5.23.3510 Sasaki, 2014, AKT activation and telomerase reverse transcriptase expression are concurrently associated with prognosis of gastric cancer, Pathobiology, 81, 36, 10.1159/000351721 Kim, 2012, Phenylbutyric acid induces the cellular senescence through an Akt/p21(WAF1) signaling pathway, Biochem Biophys Res Commun, 422, 213, 10.1016/j.bbrc.2012.04.086 Axanova, 2010, 1,25-dihydroxyvitamin D(3) and PI3K/AKT inhibitors synergistically inhibit growth and induce senescence in prostate cancer cells, Prostate, 70, 1658, 10.1002/pros.21201 Ponnala, 2011, MMP-9 silencing regulates hTERT expression via beta1 integrin-mediated FAK signaling and induces senescence in glioma xenograft cells, Cell Signal, 23, 2065, 10.1016/j.cellsig.2011.08.001 Takakura, 2005, Function of AP-1 in transcription of the telomerase reverse transcriptase gene (TERT) in human and mouse cells, Mol Cell Biol, 25, 8037, 10.1128/MCB.25.18.8037-8043.2005 Nogueira, 2011, Blockade of the NFkappaB pathway drives differentiating glioblastoma-initiating cells into senescence both in vitro and in vivo, Oncogene, 30, 3537, 10.1038/onc.2011.74 Akiyama, 2003, Nuclear factor-kappaB p65 mediates tumor necrosis factor alpha-induced nuclear translocation of telomerase reverse transcriptase protein, Cancer Res, 63, 18 Mowla, 2013, Friend or foe: emerging role of nuclear factor kappa-light-chain-enhancer of activated B cells in cell senescence, Onco Targets Ther, 6, 1221 Katakura, 2003, Decreased tumorigenicity in vivo when transforming growth factor beta treatment causes cancer cell senescence, Biosci Biotechnol Biochem, 67, 815, 10.1271/bbb.67.815 Katakura, 1999, Transforming growth factor beta triggers two independent-senescence programs in cancer cells, Biochem Biophys Res Commun, 255, 110, 10.1006/bbrc.1999.0129 Han, 2013, Indometacin ameliorates high glucose-induced proliferation and invasion via modulation of E-cadherin in pancreatic cancer cells, Curr Med Chem, 20, 4142, 10.2174/09298673113209990249 Lee, 2012, Wnt/Snail signaling regulates cytochrome C oxidase and glucose metabolism, Cancer Res, 72, 3607, 10.1158/0008-5472.CAN-12-0006 Lee, 2009, Peroxiredoxin 6 promotes lung cancer cell invasion by inducing urokinase-type plasminogen activator via p38 kinase, phosphoinositide 3-kinase, and Akt, Mol Cells, 28, 583, 10.1007/s10059-009-0152-6 Cordero-Espinoza, 2013, Increased concentrations of fructose 2,6-bisphosphate contribute to the Warburg effect in phosphatase and tensin homolog (PTEN)-deficient cells, J Biol Chem, 288, 36020, 10.1074/jbc.M113.510289 Su, 2010, Grp78 promotes the invasion of hepatocellular carcinoma, BMC Cancer, 10, 20, 10.1186/1471-2407-10-20 Zhao, 2014, Downregulation of MCT1 inhibits tumor growth, metastasis and enhances chemotherapeutic efficacy in osteosarcoma through regulation of the NF-kappaB pathway, Cancer Lett, 342, 150, 10.1016/j.canlet.2013.08.042 Li, 2013, Autophagy promotes hepatocellular carcinoma cell invasion through activation of epithelial–mesenchymal transition, Carcinogenesis, 34, 1343, 10.1093/carcin/bgt063 Ilkovitch, 2009, Urokinase-mediated recruitment of myeloid-derived suppressor cells and their suppressive mechanisms are blocked by MUC1/sec, Blood, 113, 4729, 10.1182/blood-2008-08-176438 Heavey, 2014, Strategies for co-targeting the PI3K/AKT/mTOR pathway in NSCLC, Cancer Treat Rev, 40, 445, 10.1016/j.ctrv.2013.08.006 Hemon, 2011, MHC class II engagement by its ligand LAG-3 (CD223) contributes to melanoma resistance to apoptosis, J Immunol, 186, 5173, 10.4049/jimmunol.1002050 Mineharu, 2012, Gene therapy-mediated reprogramming tumor infiltrating T cells using IL-2 and inhibiting NF-kappaB signaling improves the efficacy of immunotherapy in a brain cancer model, Neurotherapeutics, 9, 827, 10.1007/s13311-012-0144-7 Mantel, 2011, Transforming growth factor-beta: recent advances on its role in immune tolerance, Methods Mol Biol, 677, 303, 10.1007/978-1-60761-869-0_21 Niu, 2007, Up-regulation of Twist induces angiogenesis and correlates with metastasis in hepatocellular carcinoma, J Exp Clin Cancer Res, 26, 385 Li, 2009, Possible angiogenic roles for claudin-4 in ovarian cancer, Cancer Biol Ther, 8, 1806, 10.4161/cbt.8.19.9427 Hildenbrand, 1995, Urokinase plasminogen activator induces angiogenesis and tumor vessel invasion in breast cancer, Pathol Res Pract, 191, 403, 10.1016/S0344-0338(11)80726-0 Lirdprapamongkol, 2009, Vanillin suppresses metastatic potential of human cancer cells through PI3K inhibition and decreases angiogenesis in vivo, J Agric Food Chem, 57, 3055, 10.1021/jf803366f Kim, 2011, 5′-Nitro-indirubinoxime, an indirubin derivative, suppresses metastatic ability of human head and neck cancer cells through the inhibition of Integrin beta1/FAK/Akt signaling, Cancer Lett, 306, 197, 10.1016/j.canlet.2011.03.006 Tsai, 2011, Glabridin inhibits migration, invasion, and angiogenesis of human non-small cell lung cancer A549 cells by inhibiting the FAK/rho signaling pathway, Integr Cancer Ther, 10, 341, 10.1177/1534735410384860 Chien, 2009, Vascular endothelial growth factor-C (VEGF-C) promotes angiogenesis by induction of COX-2 in leukemic cells via the VEGF-R3/JNK/AP-1 pathway, Carcinogenesis, 30, 2005, 10.1093/carcin/bgp244 Swenson, 2011, Tobacco carcinogen mediated up-regulation of AP-1 dependent pro-angiogenic cytokines in head and neck carcinogenesis, Mol Carcinog, 50, 668, 10.1002/mc.20775 Dong, 2012, IKKalpha contributes to UVB-induced VEGF expression by regulating AP-1 transactivation, Nucleic Acids Res, 40, 2940, 10.1093/nar/gkr1216 Shibata, 2002, Inhibition of NF-kappaB activity decreases the VEGF mRNA expression in MDA-MB-231 breast cancer cells, Breast Cancer Res Treat, 73, 237, 10.1023/A:1015872531675 Jin, 2005, Activation of nuclear factor-kappaB contributes to induction of death receptors and apoptosis by the synthetic retinoid CD437 in DU145 human prostate cancer cells, Cancer Res, 65, 6354, 10.1158/0008-5472.CAN-04-4061 Mira, 2004, Secreted MMP9 promotes angiogenesis more efficiently than constitutive active MMP9 bound to the tumor cell surface, J Cell Sci, 117, 1847, 10.1242/jcs.01035 Clarhaut, 2009, ZEB-1, a repressor of the semaphorin 3F tumor suppressor gene in lung cancer cells, Neoplasia, 11, 157, 10.1593/neo.81074 Geng, 2013, TGF-Beta suppresses VEGFA-mediated angiogenesis in colon cancer metastasis, PLOS ONE, 8, e59918, 10.1371/journal.pone.0059918 Ma, 2010, miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis, Nat Cell Biol, 12, 247, 10.1038/ncb2024 Chu, 2013, The paradox of E-cadherin: role in response to hypoxia in the tumor microenvironment and regulation of energy metabolism, Oncotarget, 4, 446, 10.18632/oncotarget.872 Karagiannis, 2014, Collective migration of cancer-associated fibroblasts is enhanced by overexpression of tight junction-associated proteins claudin-11 and occludin, Mol Oncol, 8, 178, 10.1016/j.molonc.2013.10.008 Rosich, 2013, The phosphatidylinositol-3-kinase inhibitor NVP-BKM120 overcomes resistance signals derived from microenvironment by regulating the Akt/FoxO3a/Bim axis in chronic lymphocytic leukemia cells, Haematologica, 98, 1739, 10.3324/haematol.2013.088849 Ward, 2013, Inhibition of focal adhesion kinase (FAK) activity prevents anchorage-independent ovarian carcinoma cell growth and tumor progression, Clin Exp Metastasis, 30, 579, 10.1007/s10585-012-9562-5 Jean, 2014, Inhibition of endothelial FAK activity prevents tumor metastasis by enhancing barrier function, J Cell Biol, 204, 247, 10.1083/jcb.201307067 Yang, 2014, M-CSF cooperating with NFkappaB induces macrophage transformation from M1 to M2 by upregulating c-Jun, Cancer Biol Ther, 15, 99, 10.4161/cbt.26718 Ho, 2011, Dimerumic acid inhibits SW620 cell invasion by attenuating H(2)O(2)-mediated MMP-7 expression via JNK/C-Jun and ERK/C-Fos activation in an AP-1-dependent manner, Int J Biol Sci, 7, 869, 10.7150/ijbs.7.869 He, 2013, NF-kappaB-mediated Pax7 dysregulation in the muscle microenvironment promotes cancer cachexia, J Clin Invest, 123, 4821, 10.1172/JCI68523 Bausch, 2011, Neutrophil granulocyte derived MMP-9 is a VEGF independent functional component of the angiogenic switch in pancreatic ductal adenocarcinoma, Angiogenesis, 14, 235, 10.1007/s10456-011-9207-3 Leifler, 2013, Inflammation induced by MMP-9 enhances tumor regression of experimental breast cancer, J Immunol, 190, 4420, 10.4049/jimmunol.1202610 Novitskiy, 2012, Deletion of TGF-beta signaling in myeloid cells enhances their anti-tumorigenic properties, J Leukoc Biol, 92, 641, 10.1189/jlb.1211639 Wang, 2014, Silibinin, a novel chemokine receptor type 4 antagonist, inhibits chemokine ligand 12-induced migration in breast cancer cells, Phytomedicine, 21, 1310, 10.1016/j.phymed.2014.06.018 Wang, 2014, Silibinin inhibits proliferation, induces apoptosis and causes cell cycle arrest in human gastric cancer MGC803 cells via STAT3 pathway inhibition, Asian Pac J Cancer Prev, 15, 6791, 10.7314/APJCP.2014.15.16.6791 Deep, 2013, Targeting tumor microenvironment with silibinin: promise and potential for a translational cancer chemopreventive strategy, Curr Cancer Drug Targets, 13, 486, 10.2174/15680096113139990041 Itoh, 2010, Antineoplastic effects of gamma linolenic Acid on hepatocellular carcinoma cell lines, J Clin Biochem Nutr, 47, 81, 10.3164/jcbn.10-24 Miyake, 2009, Gamma-linolenic acid inhibits both tumour cell cycle progression and angiogenesis in the orthotopic C6 glioma model through changes in VEGF, Flt1, ERK1/2, MMP2, cyclin D1, pRb, p53 and p27 protein expression, Lipids Health Dis, 8, 8, 10.1186/1476-511X-8-8 Kubota, 2013, Eicosapentaenoic acid modifies cytokine activity and inhibits cell proliferation in an oesophageal cancer cell line, Anticancer Res, 33, 4319 Kobayashi, 2005, Suppressing effects of daily oral supplementation of beta-glucan extracted from Agaricus blazei Murill on spontaneous and peritoneal disseminated metastasis in mouse model, J Cancer Res Clin Oncol, 131, 527, 10.1007/s00432-005-0672-1 Jin, 2007, Grifolin induces apoptosis via inhibition of PI3K/AKT signalling pathway in human osteosarcoma cells, Apoptosis, 12, 1317, 10.1007/s10495-007-0062-z Lee, 2013, Anti-cancer effect and apoptosis induction of cordycepin through DR3 pathway in the human colonic cancer cell HT-29, Food Chem Toxicol, 60, 439, 10.1016/j.fct.2013.07.068 Yao, 2014, Cordycepin suppresses integrin/FAK signaling and epithelial–mesenchymal transition in hepatocellular carcinoma, Anticancer Agents Med Chem, 14, 29, 10.2174/18715206113139990305 Lee, 2009, Cordycepin causes p21WAF1-mediated G2/M cell-cycle arrest by regulating c-Jun N-terminal kinase activation in human bladder cancer cells, Arch Biochem Biophys, 490, 103, 10.1016/j.abb.2009.09.001 Yoshikawa, 2008, Cordycepin (3′-deoxyadenosine) inhibits the growth of B16-BL6 mouse melanoma cells through the stimulation of adenosine A3 receptor followed by glycogen synthase kinase-3beta activation and cyclin D1 suppression, Naunyn Schmiedebergs Arch Pharmacol, 377, 591, 10.1007/s00210-007-0218-y Zhu, 2005, Effects of Ganoderma lucidum polysaccharides on proliferation and cytotoxicity of cytokine-induced killer cells, Acta Pharmacol Sin, 26, 1130, 10.1111/j.1745-7254.2005.00171.x Xie, 2006, Ganoderma lucidum extract inhibits proliferation of SW 480 human colorectal cancer cells, Exp Oncol, 28, 25 Jiang, 2008, Ganoderic acids suppress growth and invasive behavior of breast cancer cells by modulating AP-1 and NF-kappaB signaling, Int J Mol Med, 21, 577 Cheng, 2013, Triterpenes from Poria cocos suppress growth and invasiveness of pancreatic cancer cells through the downregulation of MMP-7, Int J Oncol, 42, 1869, 10.3892/ijo.2013.1902 Mateen, 2013, Chemopreventive and anti-cancer efficacy of silibinin against growth and progression of lung cancer, Nutr Cancer, 65, 3, 10.1080/01635581.2013.785004 Ting, 2013, Molecular mechanisms of silibinin-mediated cancer chemoprevention with major emphasis on prostate cancer, AAPS J, 15, 707, 10.1208/s12248-013-9486-2 Singh, 2004, Oral silibinin inhibits lung tumor growth in athymic nude mice and forms a novel chemocombination with doxorubicin targeting nuclear factor kappaB-mediated inducible chemoresistance, Clin Cancer Res, 10, 8641, 10.1158/1078-0432.CCR-04-1435 Tyagi, 2002, Antiproliferative and apoptotic effects of silibinin in rat prostate cancer cells, Prostate, 53, 211, 10.1002/pros.10146 Jing, 2013, Omega-3 polyunsaturated fatty acids and cancer, Anticancer Agents Med Chem, 13, 1162, 10.2174/18715206113139990319 Hull, 2013, Nutritional agents with anti-inflammatory properties in chemoprevention of colorectal neoplasia, Recent Results Cancer Res, 191, 143, 10.1007/978-3-642-30331-9_8 Harnack, 2010, IL-1 receptor antagonist anakinra enhances tumour growth inhibition in mice receiving peptide vaccination and beta-(1-3), (1-6)-d-glucan, Anticancer Res, 30, 3959 Ren, 2012, Cordycepin suppresses TNF-alpha-induced NF-kappaB activation by reducing p65 transcriptional activity, inhibiting IkappaBalpha phosphorylation, and blocking IKKgamma ubiquitination, Int Immunopharmacol, 14, 698, 10.1016/j.intimp.2012.10.008 Kim, 2011, Cordycepin blocks lung injury-associated inflammation and promotes BRCA1-deficient breast cancer cell killing by effectively inhibiting PARP, Mol Med, 17, 893, 10.2119/molmed.2011.00032 Matsumoto, 2009, A component of polysaccharide peptidoglycan complex on Lactobacillus induced an improvement of murine model of inflammatory bowel disease and colitis-associated cancer, Immunology, 128, e170, 10.1111/j.1365-2567.2008.02942.x Joseph, 2011, Antitumor and anti-inflammatory activities of polysaccharides isolated from Ganoderma lucidum, Acta Pharm, 61, 335, 10.2478/v10007-011-0030-6 Li, 2012, Ganoderic acids suppress growth and angiogenesis by modulating the NF-kappaB signaling pathway in breast cancer cells, Int J Clin Pharmacol Ther, 50, 712, 10.5414/CP201663 Ling, 2010, Pachymic acid inhibits cell growth and modulates arachidonic acid metabolism in nonsmall cell lung cancer A549 cells, Mol Carcinog, 49, 271, 10.1002/mc.20597 Raina, 2013, Effect of silibinin in human colorectal cancer cells: targeting the activation of NF-kappaB signaling, Mol Carcinog, 52, 195, 10.1002/mc.21843 Pardini, 2006, Nutritional intervention with omega-3 fatty acids enhances tumor response to anti-neoplastic agents, Chem Biol Interact, 162, 89, 10.1016/j.cbi.2006.05.012 Jiang, 1997, Regulation of desmosomal cell adhesion in human tumour cells by polyunsaturated fatty acids, Clin Exp Metastasis, 15, 593, 10.1023/A:1018435229087 Ghosh-Choudhury, 2009, Fish oil targets PTEN to regulate NFkappaB for downregulation of anti-apoptotic genes in breast tumor growth, Breast Cancer Res Treat, 118, 213, 10.1007/s10549-008-0227-7 Nikolakopoulou, 2013, Omega-3 polyunsaturated fatty acids selectively inhibit growth in neoplastic oral keratinocytes by differentially activating ERK1/2, Carcinogenesis, 34, 2716, 10.1093/carcin/bgt257 Schley, 2007, (n-3) PUFA alter raft lipid composition and decrease epidermal growth factor receptor levels in lipid rafts of human breast cancer cells, J Nutr, 137, 548, 10.1093/jn/137.3.548 Ye, 2007, Grifolin, a potential antitumor natural product from the mushroom Albatrellus confluens, induces cell-cycle arrest in G1 phase via the ERK1/2 pathway, Cancer Lett, 258, 199, 10.1016/j.canlet.2007.09.001 Wong, 2010, Cordycepin inhibits protein synthesis and cell adhesion through effects on signal transduction, J Biol Chem, 285, 2610, 10.1074/jbc.M109.071159 Suarez-Arroyo, 2013, Anti-tumor effects of Ganoderma lucidum (Reishi) in inflammatory breast cancer in in vivo and in vitro models, PLOS ONE, 8, e57431, 10.1371/journal.pone.0057431 Jiang, 2004, Ganoderma lucidum inhibits proliferation and induces apoptosis in human prostate cancer cells PC-3, Int J Oncol, 24, 1093 Zhao, 2011, Ganoderma lucidum exerts anti-tumor effects on ovarian cancer cells and enhances their sensitivity to cisplatin, Int J Oncol, 38, 1319 Wu, 2012, Ganoderic acid DM, a natural triterpenoid, induces DNA damage, G1 cell cycle arrest and apoptosis in human breast cancer cells, Fitoterapia, 83, 408, 10.1016/j.fitote.2011.12.004 Singh, 2004, A cancer chemopreventive agent silibinin, targets mitogenic and survival signaling in prostate cancer, Mutat Res, 555, 21, 10.1016/j.mrfmmm.2004.05.017 Li, 2008, Silibinin inhibits cell growth and induces apoptosis by caspase activation, down-regulating survivin and blocking EGFR-ERK activation in renal cell carcinoma, Cancer Lett, 272, 61, 10.1016/j.canlet.2008.06.033 Mateen, 2010, Silibinin inhibits human nonsmall cell lung cancer cell growth through cell-cycle arrest by modulating expression and function of key cell-cycle regulators, Mol Carcinog, 49, 247, 10.1002/mc.20595 Serini, 2009, Dietary polyunsaturated fatty acids as inducers of apoptosis: implications for cancer, Apoptosis, 14, 135, 10.1007/s10495-008-0298-2 Morin, 2013, Anti-proliferative effects of a new docosapentaenoic acid monoacylglyceride in colorectal carcinoma cells, Prostaglandins Leukot Essent Fatty Acids, 89, 203, 10.1016/j.plefa.2013.07.004 Akiyama, 2011, Agaritine from Agaricus blazei Murrill induces apoptosis in the leukemic cell line U937, Biochim Biophys Acta, 1810, 519, 10.1016/j.bbagen.2011.02.010 Wu, 2007, Inhibitory effects of ethyl acetate extract of Cordyceps sinensis mycelium on various cancer cells in culture and B16 melanoma in C57BL/6 mice, Phytomedicine, 14, 43, 10.1016/j.phymed.2005.11.005 Ji, 2011, Induction of apoptosis in the SW620 colon carcinoma cell line by triterpene-enriched extracts from Ganoderma lucidum through activation of caspase-3, Oncol Lett, 2, 565, 10.3892/ol.2011.275 Radwan, 2011, Apoptotic and immune restoration effects of ganoderic acids define a new prospective for complementary treatment of cancer, J Clin Cell Immunol, S3, 4 Gapter, 2005, Induction of apoptosis in prostate cancer cells by pachymic acid from Poria cocos, Biochem Biophys Res Commun, 332, 1153, 10.1016/j.bbrc.2005.05.044 Dizaji, 2012, Synergistic effects of arsenic trioxide and silibinin on apoptosis and invasion in human glioblastoma U87MG cell line, Neurochem Res, 37, 370, 10.1007/s11064-011-0620-1 Eitsuka, 2005, Polyunsaturated fatty acids inhibit telomerase activity in DLD-1 human colorectal adenocarcinoma cells: a dual mechanism approach, Biochim Biophys Acta, 1737, 1, 10.1016/j.bbalip.2005.08.017 Eitsuka, 2004, Dual mechanisms for telomerase inhibition in DLD-1 human colorectal adenocarcinoma cells by polyunsaturated fatty acids, Biofactors, 21, 19, 10.1002/biof.552210105 Nasiri, 2013, Curcumin and silibinin inhibit telomerase expression in T47D human breast cancer cells, Asian Pac J Cancer Prev, 14, 3449, 10.7314/APJCP.2013.14.6.3449 Ebrahimnezhad, 2013, Inhibition of hTERT gene expression by silibinin-loaded PLGA-PEG-Fe3O4 in T47D breast cancer cell line, Bioimpacts, 3, 67 Thelen, 2004, Inhibition of telomerase activity and secretion of prostate specific antigen by silibinin in prostate cancer cells, J Urol, 171, 1934, 10.1097/01.ju.0000121329.37206.1b Jiang, 2000, Peroxisome proliferator activated receptor-gamma (PPAR-gamma) mediates the action of gamma linolenic acid in breast cancer cells, Prostaglandins Leukot Essent Fatty Acids, 62, 119, 10.1054/plef.1999.0131 da Silva, 2013, Effects of beta-glucan extracted from Agaricus blazei on the expression of ERCC5, CASP9, and CYP1A1 genes and metabolic profile in HepG2 cells, Hum Exp Toxicol, 32, 647, 10.1177/0960327112468173 Hara, 2009, Novel selective ligands for free fatty acid receptors GPR120 and GPR40, Naunyn Schmiedebergs Arch Pharmacol, 380, 247, 10.1007/s00210-009-0425-9 Jeong, 2011, Induction of apoptosis by cordycepin via reactive oxygen species generation in human leukemia cells, Toxicol In Vitro, 25, 817, 10.1016/j.tiv.2011.02.001 Liang, 2012, Recombinant Lz-8 from Ganoderma lucidum induces endoplasmic reticulum stress-mediated autophagic cell death in SGC-7901 human gastric cancer cells, Oncol Rep, 27, 1079, 10.3892/or.2011.1593 Singh, 2008, Silibinin inhibits colorectal cancer growth by inhibiting tumor cell proliferation and angiogenesis, Cancer Res, 68, 2043, 10.1158/0008-5472.CAN-07-6247 Sun, 2012, Enhanced MHC class I and costimulatory molecules on B16F10 cells by Ganoderma lucidum polysaccharides, J Drug Target, 20, 582, 10.3109/1061186X.2012.697167 Forghani, 2014, Silibinin inhibits accumulation of myeloid-derived suppressor cells and tumor growth of murine breast cancer, Cancer Med, 3, 215, 10.1002/cam4.186 Yang, 1998, Eicosapentaenoic acid attenuates vascular endothelial growth factor-induced proliferation via inhibiting Flk-1 receptor expression in bovine carotid artery endothelial cells, J Cell Physiol, 176, 342, 10.1002/(SICI)1097-4652(199808)176:2<342::AID-JCP12>3.0.CO;2-5 Won, 2005, Anti-inflammatory and related pharmacological activities of cultured mycelia and fruiting bodies of Cordyceps militaris, J Ethnopharmacol, 96, 555, 10.1016/j.jep.2004.10.009 Cao, 2004, Antitumor and anti-angiogenic activity of Ganoderma lucidum polysaccharides peptide, Acta Pharmacol Sin, 25, 833 Meng, 2013, Effect of n-3 and n-6 unsaturated fatty acids on prostate cancer (PC-3) and prostate epithelial (RWPE-1) cells in vitro, Lipids Health Dis, 12, 160, 10.1186/1476-511X-12-160 Bachi, 2009, Leukotriene B4 creates a favorable microenvironment for murine melanoma growth, Mol Cancer Res, 7, 1417, 10.1158/1541-7786.MCR-09-0038 Wu, 2012, Eicosapentaenoic acid and docosahexaenoic acid inhibit macrophage-induced gastric cancer cell migration by attenuating the expression of matrix metalloproteinase 10, J Nutr Biochem, 23, 1434, 10.1016/j.jnutbio.2011.09.004 Han, 2009, Antimetastatic and immunomodulating effect of water extracts from various mushrooms, J Acupunct Meridian Stud, 2, 218, 10.1016/S2005-2901(09)60058-3 Chen, 2013, The application of fungal beta-glucans for the treatment of colon cancer, Anticancer Agents Med Chem, 13, 725, 10.2174/1871520611313050007 Jeong, 2013, Cordycepin-enriched Cordyceps militaris induces immunomodulation and tumor growth delay in mouse-derived breast cancer, Oncol Rep, 30, 1996, 10.3892/or.2013.2660 Lu, 2014, Antagonism by Ganoderma lucidum polysaccharides against the suppression by culture supernatants of B16F10 melanoma cells on macrophage, Phytother Res, 28, 200, 10.1002/ptr.4980 Sliva, 2012, Mushroom Ganoderma lucidum prevents colitis-associated carcinogenesis in mice, PLoS One, 7, e47873, 10.1371/journal.pone.0047873 Ling, 2011, Pachymic acid impairs breast cancer cell invasion by suppressing nuclear factor-kappaB-dependent matrix metalloproteinase-9 expression, Breast Cancer Res Treat, 126, 609, 10.1007/s10549-010-0929-5 Xu, 2013, Synergistic inhibition of breast cancer metastasis by silibinin-loaded lipid nanoparticles containing TPGS, Int J Pharm, 454, 21, 10.1016/j.ijpharm.2013.06.053 Peng, 2005, Kinetic characterization of novel pyrazole TGF-beta receptor I kinase inhibitors and their blockade of the epithelial–mesenchymal transition, Biochemistry, 44, 2293, 10.1021/bi048851x Niu, 2009, A low molecular weight polysaccharide isolated from Agaricus blazei suppresses tumor growth and angiogenesis in vivo, Oncol Rep, 21, 145 Niu, 2009, A low molecular weight polysaccharide isolated from Agaricus blazei Murill (LMPAB) exhibits its anti-metastatic effect by down-regulating metalloproteinase-9 and up-regulating Nm23-H1, Am J Chin Med, 37, 909, 10.1142/S0192415X09007351 Su, 2011, Blazeispirol A from Agaricus blazei fermentation product induces cell death in human hepatoma Hep 3B cells through caspase-dependent and caspase-independent pathways, J Agric Food Chem, 59, 5109, 10.1021/jf104700j Ye, 2005, Grifolin, a potential antitumor natural product from the mushroom Albatrellus confluens, inhibits tumor cell growth by inducing apoptosis in vitro, FEBS Lett, 579, 3437, 10.1016/j.febslet.2005.05.013 Luo, 2011, Grifolin, a potent antitumour natural product upregulates death-associated protein kinase 1 DAPK1 via p53 in nasopharyngeal carcinoma cells, Eur J Cancer, 47, 316, 10.1016/j.ejca.2010.09.021 Luo, 2011, DAPK1 mediates the G1 phase arrest in human nasopharyngeal carcinoma cells induced by grifolin, a potential antitumor natural product, Eur J Pharmacol, 670, 427, 10.1016/j.ejphar.2011.08.026 Yeh, 2009, Cytotoxic triterpenes from Antrodia camphorata and their mode of action in HT-29 human colon cancer cells, Cancer Lett, 285, 73, 10.1016/j.canlet.2009.05.002 Hsieh, 2010, Methyl antcinate A from Antrodia camphorata induces apoptosis in human liver cancer cells through oxidant-mediated cofilin- and Bax-triggered mitochondrial pathway, Chem Res Toxicol, 23, 1256, 10.1021/tx100116a Tsai, 2010, Methylantcinate A induces tumor specific growth inhibition in oral cancer cells via Bax-mediated mitochondrial apoptotic pathway, Bioorg Med Chem Lett, 20, 6145, 10.1016/j.bmcl.2010.08.006 Hsieh, 2011, Antcin B and its ester derivative from Antrodia camphorata induce apoptosis in hepatocellular carcinoma cells involves enhancing oxidative stress coincident with activation of intrinsic and extrinsic apoptotic pathway, J Agric Food Chem, 59, 10943, 10.1021/jf202771d Rao, 2011, Identification of antrocin from Antrodia camphorata as a selective and novel class of small molecule inhibitor of Akt/mTOR signaling in metastatic breast cancer MDA-MB-231 cells, Chem Res Toxicol, 24, 238, 10.1021/tx100318m Yeh, 2013, A sesquiterpene lactone antrocin from Antrodia camphorata negatively modulates JAK2/STAT3 signaling via microRNA let-7c and induces apoptosis in lung cancer cells, Carcinogenesis, 34, 2918, 10.1093/carcin/bgt255 Kumar, 2011, Antroquinonol inhibits NSCLC proliferation by altering PI3K/mTOR proteins and miRNA expression profiles, Mutat Res, 707, 42, 10.1016/j.mrfmmm.2010.12.009 Yu, 2012, Antroquinonol, a natural ubiquinone derivative, induces a cross talk between apoptosis, autophagy and senescence in human pancreatic carcinoma cells, J Nutr Biochem, 23, 900, 10.1016/j.jnutbio.2011.04.015 Du, 2012, Antileukemia component, dehydroeburicoic acid from Antrodia camphorata induces DNA damage and apoptosis in vitro and in vivo models, Phytomedicine, 19, 788, 10.1016/j.phymed.2012.03.014 Choi, 2011, Cordycepin-induced apoptosis and autophagy in breast cancer cells are independent of the estrogen receptor, Toxicol Appl Pharmacol, 257, 165, 10.1016/j.taap.2011.08.030 Lee, 2013, Apoptosis induction of human prostate carcinoma cells by cordycepin through reactive oxygen speciesmediated mitochondrial death pathway, Int J Oncol, 42, 1036, 10.3892/ijo.2013.1762 Jeong, 2012, Inhibition of migration and invasion of LNCaP human prostate carcinoma cells by cordycepin through inactivation of Akt, Int J Oncol, 40, 1697 Baik, 2012, Cordycepin induces apoptosis in human neuroblastoma SK-N-BE(2)-C and melanoma SK-MEL-2 cells, Indian J Biochem Biophys, 49, 86 Lee, 2010, Cordycepin suppresses TNF-alpha-induced invasion, migration and matrix metalloproteinase-9 expression in human bladder cancer cells, Phytother Res, 24, 1755, 10.1002/ptr.3132 Oh, 2008, Apoptosis of human hepatocarcinoma (HepG2) and neuroblastoma (SKN-SH) cells induced by polysaccharides–peptide complexes produced by submerged mycelial culture of an entomopathogenic fungus Cordyceps sphecocephala, J Microbiol Biotechnol, 18, 512 Yang, 2005, Effects of exopolysaccharide fraction (EPSF) from a cultivated Cordyceps sinensis fungus on c-Myc, c-Fos, and VEGF expression in B16 melanoma-bearing mice, Pathol Res Pract, 201, 745, 10.1016/j.prp.2005.08.007 Zhao, 2011, Ergosta-4,6,8(14),22-tetraen-3-one induces G2/M cell cycle arrest and apoptosis in human hepatocellular carcinoma HepG2 cells, Biochim Biophys Acta, 1810, 384, 10.1016/j.bbagen.2010.12.005 Chen, 2010, Cordycepin induces apoptosis of CGTH W-2 thyroid carcinoma cells through the calcium-calpain-caspase 7-PARP pathway, J Agric Food Chem, 58, 11645, 10.1021/jf1028976 Cheng, 2007, Ganoderma lucidum polysaccharides in human monocytic leukemia cells: from gene expression to network construction, BMC Genomics, 8, 411, 10.1186/1471-2164-8-411 Hsu, 2011, Ganoderma lucidum polysaccharides induce macrophage-like differentiation in human leukemia THP-1 cells via caspase and p53 activation, Evid Based Complement Alternat Med, 2011, 358717, 10.1093/ecam/nep107 Wang, 2009, Enhancement of antitumor activities in sulfated and carboxymethylated polysaccharides of Ganoderma lucidum, J Agric Food Chem, 57, 10565, 10.1021/jf902597w Huang, 2010, Ling-Zhi polysaccharides potentiate cytotoxic effects of anticancer drugs against drug-resistant urothelial carcinoma cells, J Agric Food Chem, 58, 8798, 10.1021/jf1020158 Cao, 2006, Ganoderma lucidum polysaccharides peptide inhibits the growth of vascular endothelial cell and the induction of VEGF in human lung cancer cell, Life Sci, 78, 1457, 10.1016/j.lfs.2005.07.017 Wang, 2012, Active lipids of Ganoderma lucidum spores-induced apoptosis in human leukemia THP-1 cells via MAPK and PI3K pathways, J Ethnopharmacol, 139, 582, 10.1016/j.jep.2011.11.055 Lin, 2003, Triterpene-enriched extracts from Ganoderma lucidum inhibit growth of hepatoma cells via suppressing protein kinase C, activating mitogen-activated protein kinases and G2-phase cell cycle arrest, Life Sci, 72, 2381, 10.1016/S0024-3205(03)00124-3 Thyagarajan, 2010, Triterpenes from Ganoderma lucidum induce autophagy in colon cancer through the inhibition of p38 mitogen-activated kinase (p38 MAPK), Nutr Cancer, 62, 630, 10.1080/01635580903532390 Yao, 2012, Inhibition of the JAK-STAT3 signaling pathway by ganoderic acid A enhances chemosensitivity of HepG2 cells to cisplatin, Planta Med, 78, 1740, 10.1055/s-0032-1315303 Chen, 2008, Ganoderic acid Me inhibits tumor invasion through down-regulating matrix metalloproteinases 2/9 gene expression, J Pharmacol Sci, 108, 212, 10.1254/jphs.SC0080019 Liu, 2011, Ganoderic acid Mf and S induce mitochondria mediated apoptosis in human cervical carcinoma HeLa cells, Phytomedicine, 18, 349, 10.1016/j.phymed.2010.08.019 Chen, 2011, p53 is important for the anti-invasion of ganoderic acid T in human carcinoma cells, Phytomedicine, 18, 719, 10.1016/j.phymed.2011.01.011 Tang, 2006, Ganoderic acid T from Ganoderma lucidum mycelia induces mitochondria mediated apoptosis in lung cancer cells, Life Sci, 80, 205, 10.1016/j.lfs.2006.09.001 Liu, 2007, The anti-androgen effect of ganoderol B isolated from the fruiting body of Ganoderma lucidum, Bioorg Med Chem, 15, 4966, 10.1016/j.bmc.2007.04.036 Jedinak, 2011, Ganodermanontriol, a lanostanoid triterpene from Ganoderma lucidum, suppresses growth of colon cancer cells through beta-catenin signaling, Int J Oncol, 38, 761 Weng, 2008, Lucidenic acid inhibits PMA-induced invasion of human hepatoma cells through inactivating MAPK/ERK signal transduction pathway and reducing binding activities of NF-kappaB and AP-1, Carcinogenesis, 29, 147, 10.1093/carcin/bgm261 Cui, 2007, Induction of apoptosis in SGC-7901 cells by polysaccharide–peptide GFPS1b from the cultured mycelia of Grifola frondosa GF9801, Toxicol In Vitro, 21, 417, 10.1016/j.tiv.2006.10.004 Soares, 2011, Maitake (D fraction) mushroom extract induces apoptosis in breast cancer cells by BAK-1 gene activation, J Med Food, 14, 563, 10.1089/jmf.2010.0095 Pyo, 2008, Possible immunotherapeutic potentiation with D-fraction in prostate cancer cells, J Hematol Oncol, 1, 25, 10.1186/1756-8722-1-25 Yukawa, 2012, Direct cytotoxicity of Lentinula edodes mycelia extract on human hepatocellular carcinoma cell line, Biol Pharm Bull, 35, 1014, 10.1248/bpb.b110657 Harada, 2012, Effects of lentinan alone and in combination with fluoropyrimidine anticancer agent on growth of human oral squamous cell carcinoma in vitro and in vivo, Int J Oncol, 37, 623 Shi, 2013, ROS-dependent mitochondria molecular mechanisms underlying antitumor activity of Pleurotus abalonus acidic polysaccharides in human breast cancer MCF-7 cells, PLOS ONE, 8, e64266, 10.1371/journal.pone.0064266 Lavi, 2006, An aqueous polysaccharide extract from the edible mushroom Pleurotus ostreatus induces anti-proliferative and pro-apoptotic effects on HT-29 colon cancer cells, Cancer Lett, 244, 61, 10.1016/j.canlet.2005.12.007 Lavi, 2012, Glucans from the edible mushroom Pleurotus pulmonarius inhibit colitis-associated colon carcinogenesis in mice, J Gastroenterol, 47, 504, 10.1007/s00535-011-0514-7 Xu, 2012, Extract of Pleurotus pulmonarius suppresses liver cancer development and progression through inhibition of VEGF-induced PI3K/AKT signaling pathway, PLoS One, 7, e34406, 10.1371/journal.pone.0034406 Zhang, 2006, Growth-inhibitory effects of a beta-glucan from the mycelium of Poria cocos on human breast carcinoma MCF-7 cells: cell-cycle arrest and apoptosis induction, Oncol Rep, 15, 637 Mizushina, 2004, A novel DNA topoisomerase inhibitor: dehydroebriconic acid, one of the lanostane-type triterpene acids from Poria cocos, Cancer Sci, 95, 354, 10.1111/j.1349-7006.2004.tb03215.x Ling, 2009, Polyporenic acid C induces caspase-8-mediated apoptosis in human lung cancer A549 cells, Mol Carcinog, 48, 498, 10.1002/mc.20487 Kikuchi, 2011, Cytotoxic and apoptosis-inducing activities of triterpene acids from Poria cocos, J Nat Prod, 74, 137, 10.1021/np100402b